Skip to main content

ATN Scientific Publications

This page is no longer updated. Please visit https://sites.cscc.unc.edu/atn/view/biblio/year for the latest list of ATN publications.

 

PUBLISHED SCIENTIFIC ABSTRACTS:

2017

5 U01 HD 40533 and 5 U01 HD 40474
Havens PL, Stephensen C, Van Loan M, Rutledge B, Harris B, Flynn PM, Gordon C, Kapogiannis B, Mulligan K, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. High dose vitamin D3 increases spine bone density in HIV+ youth on Tenofovir (TDF). Poster Presentation at the Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, WA, February 13-16, 2017. (ATN 109)

UM1CA121974, 5 U01 HD 40533 and 5 U01 HD 40474
Kahn JA, Lee JL, Belzer M, Palefsky JM for the AIDS Malignancy Consortium, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Most HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs About Safer Sexual Behaviors After Human Papillomavirus Vaccination. Poster presentation to the 31st International Papillomavirus Conference – HPV 2017, Cape Town, South Africa, February 28-March 4, 2017.  (AMC 072)

UM1CA121974, 5 U01 HD 40533 and 5 U01 HD 40474
Palefsky JM , Lee JL, Rudy B, Belzer M, Kahn JA, the AIDS Malignancy Consortium, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Pre-Vaccination Exposure to HPV Vaccine Types in 13-To-26 Year Old HIV-Positive Men Who Have Sex With Men. Oral presentation to the 31st International Papillomavirus Conference – HPV 2017, Cape Town, South Africa, February 28-March 4, 2017.  (AMC 072)

5 U01 HD 40533 and 5 U01 HD 40474
Tanner AE, Philbin MM, Ma A, Chambers B, Lally M, Fortenberry JD, Nichols S, Lee S, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Examining the transition process from adolescent to adult HIV care for youth across 14 Adolescent Trials Network (ATN) clinical sites: The adult clinic perspective from Project CATCH. Poster presentation to the Society for Adolescent Health and Medicine Meeting, New Orleans, LA, March 8-11, 2017.  (ATN 135)

5 U01 HD 40533 and 5 U01 HD 40474
Philbin MM, Tanner AE, Chambers, BD, Ma A, Ware S, Lee S, Fortenberry JD, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Transitioning HIV-positive adolescents to adult care at 14 clinics across the United States: Using adolescent and adult providers’ insights to create multi-level solutions to address transition barriers. Oral presentation to the Population Association of America meeting in Chicago, IL, April 27-29, 2017.  (ATN 135)

5 U01 HD 40533 and 5 U01 HD 40474
Tarantino N, Brown L, Whiteley L, Fernandez MI, Nichols SL, Harper GW, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Number of Past-Year Missed Clinic Visits as an Indicator of Current Health Functioning among Young People Living with HIV. Poster presentation to the Association for Psychological Science Annual Convention in Boston, MA, May 25-28, 2017.  (ATN 086-106)

5 U01 HD 40533 and 5 U01 HD 40474
Bunge K, Levy L, Szydio D, Zhang J, Rierden D, Mayers K, Futterman D, Hoesley C, Hillier S, Marzinke M, Dezzutti C, Wilson C, Soto-Torres L, Kapogiannis B, Nel A, Squires K, and the MTN-023/IPM 030 Protocol Team. Safety and Acceptability Trial of the Dapivirine Ring in US Adolescents. Oral presentation to the IAS Annual Conference 2017 in Paris, France, July 23-26, 2017.

5 U01 HD 40533 and 5 U01 HD 40474
Philbin MM, Tanner AE, Ma A, Chambers BD, Ware S, Kennard EN, Hussen SA, Lee S, Fortenberry JD, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Adolescent and adult providers’ definition and approach to help HIV-infected youths’ successful transition to adult care. Poster presentation to the American Association of Public Health meeting in Atlanta, GA, November 4-8, 2017. (ATN 135)

 

2016

5 U01 HD 40533 and 5 U01 HD 40474
Chutuape K, Muyeed A, Willard N, Greenberg L, Ellen J and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Adding to the HIV Prevention Portfolio: The Achievement of Structural Changes by Coalitions Targeting to Reduce HIV Risk in Adolescents and Young Adults through Community Mobilization in Urban Areas Across the US and Puerto Rico. Oral presentation at the Society for Adolescent Health and Medicine Conference, Washington D.C., March 9-12, 2016. (ATN 040)

5 U01 HD 40533 and 5 U01 HD 40474
Wilson L, Gakpo R, Aldrovandi G, Rudy B, Goodenow M, Sleasman J and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Lymphocyte Activation and Bone Turnover in HIV-infected Young Adults; a sub-study Adolescent Trials Network Protocol 061. Poster presentation to the 2016 Annual Meeting of the American Academy of Asthma, Allergy and Immunology, Los Angeles, CA March 4-7, 2016. (ATN 061)

5 U01 HD 40533 and 5 U01 HD
Tanner AE, Fortenberry JD, Philbin MM, Lally M, Ma A, Chambers B and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Transition for adolescent to adult HIV care for youth across 15 clinics in the United States: Preliminary results from Project CATCH. Oral presentation at the 2016 IAS 2nd Adolescent Transition Workshop, Budapest, Hungary, April 6, 2016 (ATN 135)

5 U01 HD 40533 and 5 U01 HD 40474
Miller RL, Lindeman P, Chiaramonte D, Fortenberry JD, Boyer C, Chutuape K, Cooper-Walker B and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Evaluating Testing Strategies for Identifying High-risk Youth and Linking Youth to Prevention. Poster presentation to the 21st International AIDS Society Conference, Durban, South Africa, July 18-22, 2016.  (C2TaP)

5 U01 HD 40533 and 5 U01 HD 40474
Mulligan K, Hosek S, Kapogiannis BG, Landovitz RJ, Liu N, Cofield SS, Perumean-Chaney SE, Rutledge B, Havens PL, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Changes in Bone Mass after Discontinuation of PrEP with Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) in Young Men Who Have Sex with Men (YMSM):  Extension Phase Results of Adolescent Trials Network (ATN) 110. Oral presentation to the 21st International AIDS Society Conference, Durban, South Africa, July 18-22, 2016.  (ATN 110)

5 U01 HD 40533 and 5 U01 HD 40474
Hosek S, Landovitz RJ, Rudy, B, Kapogiannis BG, Siberry, G, Rutledge B, Liu N, Brothers J, Rooney, J, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. An HIV Pre-Exposure Prophylaxis (PrEP) Demonstration Project and Safety Study for Adolescent MSM ages 15-17 in the United States (ATN 113). Oral presentation to the 21st International AIDS Society Conference, Durban, South Africa, July 18-22, 2016.  (ATN 113)

5 U01 HD 40533 and 5 U01 HD 40474
Mulligan K, Hosek S, Kapogiannis BG, Landovitz RJ, Liu N, Cofield SS, Perumean-Chaney SE, Rutledge B, Havens PL, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Changes in Bone Mass after Discontinuation of Pre-Exposure Prophylaxis (PrEP) with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex with Men who Lost Bone While Using PrEP:  Extension Phase Results of Adolescent Trials Network Protocol 110. Oral presentation to the 18th Workshop on Adverse Drug Reactions and Comorbidities, New York, New York, September 12-13, 2016.  (ATN 110)

 

2015

5 U01 HD 40533 and 5 U01 HD 40474
Zhang X, Nichols S, Chang K, Kaiki M, Sleasman J, Chi Y, Goodenow M, and the Adolescent Trials Network for HIV/AIDS Interventions. Substance use effects on neurocognitive and immune function among HIV-infected youth. Poster Presentation at Southern HIV and Alcohol Research Consortium (SHARC) Conference, Gainesville, FL, January 28-29, 2015. (ATN 101)

5 U01 HD 40533 and 5 U01 HD 40474
Nichols S, Garvie P, Li T, Ren W, Kapogiannis B, Rudy B, Sleasman J, Woods S, Puga A, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Neurocognition following antiretroviral initiation in behaviorally HIV-infected youth. Poster Presentation at the Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, WA, February 23-26, 2015. (ATN 071)

5 U01 HD 40533 and 5 U01 HD 40474
Tanner AE, Philbin M, DuVal A, Ellen J, Kapogiannis B, Fortenberry D and the Adolescent Trials Network for HIV/AIDS Interventions. Transitioning adolescents with HIV to adult care: Examining processes at twelve adolescent medicine clinics. Platform presentation at the 2015 Society for Adolescent Health and Medicine (SAHM) Annual Meeting, Los Angeles, CA, March 18-21, 2015. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Gilbert A, Knopf A, Fortenberry D, Hosek S, Kapogiannis B, Zimet G, and the Adolescent Trials Network for HIV/AIDS Interventions. Adolescent Self-Consent for Biomedical HIV Prevention Research: Implications for IRB Approval and Implementation. Platform presentation at the 2015 Society for Adolescent Health and Medicine (SAHM) Annual Meeting, Los Angeles, CA, March 18-21, 2015.  (ATN 113)

5 U01 HD 40533 and 5 U01 HD 40474
Knopf A, Gilbert A, Fortenberry D, Kapogiannis B, Hosek S, Zimet G, and the Adolescent Trials Network for HIV/AIDS Interventions. Implementing a multi-site HIV prevention trial requiring adolescent self-consent: Challenges encountered and lessons learned. Oral presentation at the Midwest Nursing Research Society 39th Annual Research Conference, Indianapolis, IN, April 16-19, 2015. (ATN 113)

5 U01 HD 40533 and 5 U01 HD 40474
Harper G, Jadwin-Cakmak L, Reisner S, Martinez M, Solomon L, Campbell B, Popoff E, and the Adolescent Trials Network for HIV/AIDS Interventions. Exploring Utilization of HIV related Services and Care among Transgender and Other Gender Minority Youth in the U.S. Oral presentation at the National Transgender Health Summit, Oakland, CA, April 17-18, 2015. (ATN 130)

5 U01 HD 40533 and 5 U01 HD 40474
Lemos D, Hosek S, Harper G, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Project ACCEPT: A behavioral intervention to promote engagement in care for youth newly diagnosed with HIV. Oral presentation at the 10th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 28-30, 2015. (ATN 108)

131. 5 U01 HD 40533 and 5 U01 HD 40474
Hartlieb K, Naar-King S, Lam P, Kapogiannis B, Fortenberry JD, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Nationwide Implementation of Motivational Interviewing Training to Enhance Youth Linkage to HIV Care in the US. Poster presentation at the 10th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 28-30, 2015. (ATN 128)

5 U01 HD 40533 and 5 U01 HD 40474
Garvie PA, Li S, Bethel J, Woods SP, Patton ED, Nichols SL, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Poster presentation at the 10th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 28-30, 2015. (ATN 071)

5 U01 HD 40533 and 5 U01 HD 40474
Emslie G, Brown L, Kennard B, Mayes T, Xu J, Garvie P, Worrell C, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Treatment of Depression in Adolescents and Young Adults with HIV. Oral presentation at the 10th International Conference on Child and Adolescent Psychopathology, London, England, July 20-22, 2015. (ATN 080)

5 U01 HD 40533 and 5 U01 HD 40474
Siberry G, Serrano P, Hosek S, Liu N, Brothers J, Lee S, Kapogiannis B, Wilson C, and the Adolescent Trials Network for HIV/AIDS Interventions. Recruitment Methods for a Pre-Exposure Prophylaxis (PrEP) Study with Adolescent and Young Adult Men Who Have Sex with Men (MSM). Oral presentation at the 7th International Workshop on HIV pediatrics, Vancouver, B.C., Canada, July 17-28, 2015. (ATN 110-113)

5 U01 HD 40533 and 5 U01 HD 40474
Kapogiannis B, Xu J, Mayer K, Loeb J, Greenberg L, Monte D, Koenig L.J., Bank-Shields M, Fortenberry D , and the Adolescent Trials Network for HIV/AIDS Interventions. The HIV Continuum of Care for Adolescents and Young Adults (12-24 years) Attending 13 Urban US Centers of the NICHD-ATN- CDC-HRSA SMILE Collaborative.  Poster presentation at the 8th IAS Conference on HIV Pathogenesis, Vancouver, BC, Canada, July 19-22, 2015. (ATN 116)

5 U01 HD 40533 and 5 U01 HD 40474
Hosek S, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, Liu N, Brothers J, Wilson CM, and the Adolescent Trials Network for HIV/AIDS Interventions. An HIV Pre-Exposure Prophylaxis (PrEP) Demonstration Project and Safety Study for Young MSM ages 18-22 in the United States. Oral presentation at the 8th IAS Conference on HIV Pathogenesis, Vancouver, BC, Canada, July 19-22, 2015. (ATN 110)

5 U01 HD 40533 and 5 U01 HD 40474
Mulligan K, Rutledge B, Kapogiannis B, Siberry G, Anderson, Landovitz R, Rudy B, Liu N, Rooney J, Havens P, Wilson CM, Hosek S, ATN 110 protocol team and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Bone Changes in Young Men Ages 18-22 Enrolled in a Pre-Exposure Prophylaxis (PrEP) Demonstration Project Using Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC). Oral presentation at the 17th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, Barcelona, Spain, October 21-24, 2015. (ATN 110)

5 U01 HD 40533 and 5 U01 HD 40474
Brown L, Kennard B, Emslie G Mayes T, Xu J, Whiteley L, Hawkins L, Garvie P, Tanney M, Stoff L, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Treatment of Depression in Adolescents and Young Adults with HIV. Poster presentation at the National HIV Prevention Conference hosted by the CDC, Atlanta, GA, December 6-9, 2015.  (ATN 080)

 

2014

5 U01 HD 40533 and 5 U01 HD 40474
McGregor K, Ott M, Lally M, Zimet G, and the Adolescent Trials Network for HIV/AIDS Interventions. Predictors of Adolescent Decision Making about HIV Vaccine Trial Participation. Oral presentation at the 2014 Society for Social Work and Research Conference in San Antonio, TX, January 15-19, 2014. (ATN 076)

5 U01 HD 40533 and 5 U01 HD 40474
Nichols S, Lowe A, Zhang X, Garvie P, Thornton S, Goldberger B, Hou W, Goodenow M, Sleasman JW, and the Adolescent Trials Network for HIV/AIDS Interventions. Concordance Between Self-Reported Substance Use and Toxicology Among HIV Infected and Uninfected at Risk Youth. Poster presentation at the 2014 Southern HIV and Alcohol Research Consortium Conference in Miami, FL, January 29-30, 2014. (ATN 101)

5 U01 HD 40533 and 5 U01 HD 40474
Zimet GD, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, Lally M, and the Adolescent Trials Network for HIV/AIDS Interventions. Evaluation of Interventions to Improve Adolescents’ Understanding about an HIV Vaccine Clinical Trial. Poster presentation at the 2014 Society of Pediatric Psychology Annual Conference in Philadelphia, PA, March 27-29, 2014. (ATN 076)

5 U01 HD 40533 and 5 U01 HD 40474
Rudy BJ, Kapogiannis B, Bethel J, Wilson CM, Worrell C, Li S, Squires K, Goodenow M, Agwu A, Sleasman J, and the Adolescent Trials Network for HIV/AIDS Interventions. HIV Therapy De-intensification to Atazanavir/ritonavir (ATVr) Monotherapy in Adolescents/Young Adults Maintain CD4 Gains and VL Suppression. Oral presentation at the 21th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA, March 3-6, 2014. (ATN 061)

5 U01 HD 40533 and 5 U01 HD 40474
Hosek S, Martinez J, Santos K, Balthazar C, Serrano P, Bojan K, Mehrotra M, Grant R, and the Adolescent Trials Network for HIV/AIDS Interventions. PrEP Interest, Uptake and Adherence among Young Men Who Have Sex with Men (YMSM) in the United States. Poster presentation at the 2014 Conference of Retrovirus and Opportunistic Infections (CROI) in Boston, MA, March 3-6, 2014. (ATN 082)

5 U01 HD 40533 and 5 U01 HD 40474
Tanner AE, Philbin MM, DuVal A, Ellen JM, Kapogiannis B, Fortenberry JD, and the Adolescent Trials Network for HIV/AIDS Interventions. An overview of the SMILE program: Care linkage and engagement for newly diagnosed HIV+ adolescents within fifteen adolescent medicine clinics in the United States. Oral presentation at the Society for Prevention Research 22nd Annual Meeting in Washington, DC, May 27-30, 2014. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Belzer M, Clark L, Kahana S, Sarr M, Thornton S, Olson J, Naar-King S, and the Adolescent Trials Network for HIV/AIDS Interventions. A Randomized, Controlled Pilot Study of Cell Phone Support for Youth Nonadherent to ART: Impact of the Intervention on Depression, Substance Abuse and Service Utilization. Poster presentation at the International Association of Providers of AIDS Care (IAPAC) 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 8-10, 2014. (ATN 078)

5 U01 HD 40533 and 5 U01 HD 40474
Belzer M, MacDonell KK, Naar-King S, Kahana S, Sarr M, Thornton S, Huang J, Olson J, Clark L, and the Adolescent Trials Network for HIV/AIDS Interventions. Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV Nonadherent to Antiretroviral Therapy (ART). Oral presentation at the International Association of Providers of AIDS Care (IAPAC) 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 8-10, 2014. (ATN 078)

5 U01 HD 40533 and 5 U01 HD 40474
Gross IM, Hosek S, Richards M, Fernandez MI, Huszti H, and the Adolescent Trials Network for HIV/AIDS Interventions. Using Optimal Data Analysis to Predict Antiretroviral Adherence among HIV+ Youth. Poster presentation at the International Association of Providers of AIDS Care (IAPAC) 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 8-10, 2014. (ATN 086/106)

5 U01 HD 40533 and 5 U01 HD 40474
Saberi P, Mayer K, Vittinghoff E, Naar-King S, and the Adolescent Trials Network for HIV/AIDS Interventions. Correlation between Use of Antiretroviral Adherence Devices by HIV-infected Youth and Plasma HIV RNA and Self-reported Adherence. Poster presentation at the International Association of Providers of AIDS Care (IAPAC) 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, June 8-10, 2014. (ATN 086/106)

5 U01 HD 40533 and 5 U01 HD 40474
Miller RL, Janulis PF, Reed SJ, Fortenberry JD, Kapogiannis BG, and the Adolescent Trials Network for HIV/AIDS Interventions. Evaluating Referral Infrastructures to Support Youth Linkage to HIV Care. Poster presentation at the 20th International AIDS Conference, Melbourne, Australia, July 20-25, 2014. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Kapogiannis BG, Leister E, Siberry G, Van Dyke R, Rudy B, Flynn P, and Williams P. Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth. Poster presentation at the 20th International AIDS Conference, Melbourne, Australia, July 20-25, 2014. (ATN 119)

5 U01 HD 40533 and 5 U01 HD 40474
Wilson PA, Kahana SY, Fernandez MI, Harper G, Wilson C, Hightow-Weidman L, and the Adolescent Trials Network for HIV/AIDS Interventions. Health-related and Psychosocial Correlates of Sexual Risk Behavior among HIV-positive Young Men Who Have Sex with Men in the United States. Poster presentation at the 20th International AIDS Conference, Melbourne, Australia, July 20-25, 2014. (ATN 086)

5 U01 HD 40533 and 5 U01 HD 40474
Kapogiannis BG, Leister E, Siberry G, Van Dyke R, Rudy B, Flynn P, and Williams P. Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth. Poster Presentation at the 6th International Workshop on HIV Paediatrics, Melbourne, Australia, July 18-19, 2014. (ATN 119)

5 U01 HD 40533 and 5 U01 HD 40474
Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML, and the Adolescent Medicine Trials Network. Behavioral, Immunologic, and Virologic Correlates of Oral Human Papillomavirus Infection in HIV-Infected Adolescents. Poster presentation at the 29th International Papillomavirus Conference in Seattle, August 21-25, 2014. (ATN 114)

5 U01 HD 40533 and 5 U01 HD 40474
Zimet GD, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, Lally M, and the Adolescent Trials Network for HIV/AIDS Interventions. Evaluation of Interventions to Improve Adolescents’ Understanding about an HIV Vaccine Clinical Trial. Poster presentation at the symposium at the Society for Developmental and Behavioral Pediatrics Meeting, Nashville, TN, September 19-22, 2014. (ATN 076)

5 U01 HD 40533 and 5 U01 HD 40474
Brown, LK, Whitely, L, Harper, GW, Nichols, S, Nieves, A, the ATN 086 Protocol Team, and the Adolescent Trials Network for HIV/AIDS Interventions. Mental Health Symptoms among Youth Living with HIV. Poster presentation at the 2014 American Academy of Child and Adolescent Psychiatry (AACAP) conference, San Diego, CA, October 20-26, 2014. (ATN 086-106)

5 U01 HD 40533 and 5 U01 HD 40474
Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MI, Rubin D and the Adolescent Medicine Trials Network for HIV/AIDS Interventions.  Health and Psychosocial Outcomes Among HIV+ Young Transgender Women Engaged in Medical Care. Platform Presentation at the National CFAR Meeting, Providence, RI, November 5-7 2014. (ATN 086-106)

 

2013

5 U01 HD 40533 and 5 U01 HD 40474
Nichols S, Bethel J, Garvie P, Patton D, Thornton S, Kapogiannis B, Ren W, Li S, Major-Wilson H, Woods S, and the Adolescent Trials Network for HIV/AIDS Interventions. Neurocognitive Functioning in Antiretroviral Therapy-Naïve Youth with Behaviorally Acquired HIV. Poster presentation at the 2013 Conference on Retroviruses and Opportunistic Infections in Atlanta, GA, March 3-6, 2013. (ATN 071)

5 U01 HD 40533 and 5 U01 HD 40474
Hosek S, Telander K, Balthazar C, Lally M, Siberry G, Kapogiannis B, Wilson C, and the Adolescent Trials Network for HIV/AIDS Interventions. Does Sexual Behavior Influence Adherence to Pre-Exposure Prophylaxis? Data from a PrEP Trial among Young Men Who Have Sex with Men. Poster presentation at the 2013 Conference on Retroviruses and Opportunistic Infections in Atlanta, GA, March 3-6, 2013. (ATN 082)

5 U01 HD 40533 and 5 U01 HD 40474
Belzer M, Naar-King S, Olson J, Clark L, Sarr M, and the Adolescent Trials Network for HIV/AIDS Interventions. A Pilot Study Using Cell Phone Interactions to Improve HIV Medication Adherence in Adolescents Who Have Previously Failed Antiretroviral Therapy. Oral presentation at the 2013 Society for Adolescent Health and Medicine Annual Meeting in Atlanta, GA, March 13-16, 2013. (ATN 078)

5 U01 HD 40533 and 5 U01 HD 40474
Naar-King S, Outlaw AY, Parsons JT, and the Adolescent Trials Network for HIV/AIDS Interventions. Motivational Enhancement System for Adherence (MESA): Pilot Randomized Trial of a Brief Computer-Delivered Prevention Intervention for Youth Initiating Antiretroviral Treatment. Oral presentation at the International Society for Research on Internet Interventions (ISRII) 6th Scientific Meeting in Chicago, IL, May 16 – 18, 2013. (ATN 072)

5 U01 HD 40533 and 5 U01 HD 40474
Naar-King S, Outlaw AY, Parsons JT, and the Adolescent Trials Network for HIV/AIDS Interventions. Motivational Enhancement System for Adherence (MESA): Pilot Randomized Trial of a Brief Computer-Delivered Prevention Intervention for Youth Initiating Antiretroviral Treatment. Oral presentation at the American Psychological Association 2013 Meeting in Honolulu, HI, July 31 – August 4, 2013. (ATN 072)

5 U01 HD 40533 and 5 U01 HD 40474
Nellum A, Williams A, and the Adolescent Trials Network for HIV/AIDS Interventions. Connecting to Protect: Implications of a CBPR Approach to Illustrate Geospatial Patterns of Adolescent HIV/STI Risk Indicators. Poster presentation at the 141st APHA Annual Meeting in Boston, MA, November 2-6, 2013. (ATN 105)

5 U01 HD 40533 and 5 U01 HD 40562
Stines S, Walker BC, Willard N, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. Structural Approaches for HIV Prevention among Young Men and Transgender Women of Color who have Sex with Men. Poster presentation at the International Conference on STIGMA in Washington, DC, November 22, 2013. (ATN 040)

 

2012

5 U01 HD 40533 and 5 U01 HD 40474
Fortenberry J, Brown R, Humphreys M, Martinez M and the Adolescent Trials Network for HIV/AIDS Interventions. CDC-ATN/NICHD Testing and Linkage to Care Project:  An update on multisite initiative to improve LTC for HIV positive youth. Poster presentation at the 2012 National African American MSM Leadership Conference on HIV/AIDS and other Health Disparities in New Orleans, LA, January 19-22, 2012. (ATN 093)

3 U01 HD 40533 - ARRA
Philbin MM, Tanner AE, Duval A, Ellen J, Kapogiannis B, Fortenberry JD. Linkage to care and engagement in care for newly diagnosed HIV-positive youth within fifteen Adolescent Medicine Clinics in the United States. Poster presentation at the 2012 Society for Adolescent Health and Medicine conference in New Orleans, LA., March 14-17, 2012. (ATN 093)

3 U01 HD 40533 - ARRA
Tanner AE, Philbin MM, Duval A, Ellen J, Kapogiannis B, Fortenberry JD. The importance of “youth friendly” clinical environments for linking newly diagnosed HIV-positive adolescents to care. Poster presentation at the 2012 Society for Adolescent Health and Medicine conference in New Orleans, LA., March 14-17, 2012. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Giguere R, Zimet GD, Kahn JA, Dolezal C, Mabragaña M, Carballo-Diéguez A, McGowan I. The Motivations and Experiences of Young Women in a Microbicide Trial. Oral presentation at the 2012 International Microbicides Conference in Sydney, Australia, April 15-18, 2012. (ATN 062)

5 U01 HD 40533 and 5 U01 HD 40474
Kapogiannis B, Fortenberry JD, Ellen J, Xu J, Willard N, DuVal A, Pace J, Loeb J, Bethel J, Wilson C, the ATN 093 Team, and the Adolescent Trials Network for HIV/AIDS Interventions. The Strategic Multisite Initiative for the Identification, Linkage and Engagement to Care of HIV-Infected Youth (SMILE): Can Treatment As Prevention Work for American Minority Youth? Poster presentation at the International AIDS Society Conference in Washington, DC, July 22-27, 2012. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Philbin MM, Tanner AE, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Trials Network for HIV/AIDS Interventions. Linking HIV-positive adolescents to care in 15 different clinics across the United States: Creating solutions to address structural barriers for linkage to care. Poster presentation at the International AIDS Society Conference in Washington, DC, July 22-27, 2012. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Kahn J, Xu J, Kapogiannis B, Rudy BJ, Liu N, Gonin R, Wilson C, Worrell C, Squires K, and the Adolescent Trials Network for HIV/AIDS Interventions. Immunogenicity of the HPV-6, -11, -16, -18 Vaccine in HIV-Infected Young Women. Oral presentation at the International AIDS Society Conference in Washington, DC, July 22-27, 2012. (ATN 064)

5 U01 HD 40533 and 5 U01 HD 40474
Tanner AE, Philbin MM, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Trials Network for HIV/AIDS Interventions. Models of relationships between local health departments and adolescent medicine clinics: Importance for adolescent HIV linkage to care. Poster presentation at the International AIDS Society Conference in Washington, DC, July 22-27, 2012. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Hightow-Weidman L, Boyer CB, Li SX, Vellala K, Gonin R, Henry-Reid L, Futterman D, Maturo D, Straub DM, Siberry G, Kapogiannis BG, Gassama ML, Lopez B, Ellen JM, and the Adolescent Trials Network for HIV/AIDS Interventions. Exploring the Sexual Relationships of HIV-positive and Negative Black and Hispanic Young Women and their Male Sexual Partners. Poster presentation at the International AIDS Society Conference in Washington, DC, July 22-27, 2012. (ATN 084)

5 U01 HD 40533 and 5 U01 HD 40474
Bruce D, Kahana S, Harper GW, Fernandez MI, and the Adolescent Trials Network for HIV/AIDS Interventions. Alcohol Use Predicts Sexual Risk Behavior with HIV-Negative or Partners of Unknown Status Among Young HIV-Positive Men Who Have Sex with Men. Poster presentation at the International AIDS Society Conference in Washington, DC, July 22-27, 2012. (ATN 070)

5 U01 HD 40533 and 5 U01 HD 40474
Nichols S, Sleasman J, Goodenow M, Lowe A, Hou W, Garvie P, Patton D, Zhang X, and the Adolescent Trials Network for HIV/AIDS Interventions. Substance use self-report by adolescents with HIV: How valid is it? Poster presentation at the 4th International Workshop on HIV Pediatrics in Washington, DC, July 20-21, 2012. (ATN 071/101)

5 U01 HD 40533 and 5 U01 HD 40474
Hosek S, Siberry G, Lally M, Bell M, Fernandez MI, Rutledge B, Kapogiannis B, Wilson C, and the Adolescent Trials Network for HIV/AIDS Interventions. A First Look at Open Label Use of Pre-Exposure Prophylaxis among Young Men Who Have Sex with Men. Poster presentation at the 4th International Workshop on HIV Pediatrics in Washington, D.C., July 20-21, 2012. (ATN 082)

5 U01 HD 40533 and 5 U01 HD 40474
Kapogiannis B, Fortenberry JD, Ellen J, Xu J, Willard N, DuVal A, Pace J, Loeb J, Bethel J, Wilson C, the ATN 093 Team, and the Adolescent Trials Network for HIV/AIDS Interventions. The Strategic Multisite Initiative for the Identification, Linkage and Engagement to Care of HIV-Infected Youth (SMILE): Can Treatment As Prevention Work for American Minority Youth? Poster presentation at the 4th International Workshop on HIV Pediatrics in Washington, D.C., July 20-21, 2012. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Havens PL, Mulligan K, Hazra R, Van Loan MD, Rutledge BN, Pan CG, Flynn PM, Lujan-Zilberman J, Gordon CM, Woodhouse LR, Kiser J, Meyer WA, Baker AM, Liu NX, Wilson CM, Stephensen CB. Increase in Fibroblast Growth Factor 23 (FGF23) in response to Vitamin D3 supplementation in HIV-infected adolescents and young adults on tenofovir-containing cART: Adolescent Trials Network (ATN) study 063. Oral presentation at the 14th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV in Washington, D.C., July 19-21, 2012. (ATN 063)

5 U01 HD 40533 and 5 U01 HD 40474
Philbin MM, Tanner AE, DuVal A, Ellen J, Kapogiannis B, and Fortenberry JD, and the Adolescent Trials Network for HIV/AIDS Interventions. Understanding linkage to care and engagement in care across 15 Adolescent Medicine Trials Network (ATN) clinics: Adolescent provider perspectives and implications for newly HIV-infected youth. Oral presentation at the 2012 American Public Health Association (APHA) conference in San Francisco, CA, October 27-31, 2012. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Tanner AE, Philbin MM, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD. Linking HIV-positive adolescents to care: The role and process of ‘youth friendly’ clinical environments. Poster presentation at the 2012 American Public Health Association (APHA) conference in San Francisco, CA, October 27-31, 2012. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Harper GW, Fernandez MI, Bruce D, Hosek SG, Jacobs RJ, and the Adolescent Trials Network for HIV/AIDS Interventions. The Role of Multiple Identities in Engagement in Care among Gay/Bisexual Male Adolescents Living with HIV. Oral presentation at the 2012 American Public Health Association (APHA) conference in San Francisco, CA, October 27-31, 2012. (ATN 070)

 

2011

5 U01 HD 40533 and 5 U01 HD 40474
Syed SS, Balluz RS, Kabagambe EK, Wilson CM, Sleasman J, Kapogiannis B, Nachman S. ATN 083: Longitudinal Changes in Cardiovascular Risk Markers Among HIV Infected and At Risk Adolescents. Poster presentation at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, February 27-March 2, 2011. (ATN 083)

5 U01 HD 40533 and 5 U01 HD 40474
Mulligan K, Harris R, Emmanuel P, Fielding R, Hardin D, Worrell C, Kapogiannis B, Monte D, Sleasman J, Aldrovandi G and the ATN 021b Study Team. Low Bone Mass in Behaviorally HIV-Infected Young Men on Antiretroviral Therapy (ART) Adolescent Trials Network (ATN) Protocol  021b. Poster presentation at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, February 27-March 2, 2011. (ATN 021b)

5 U01 HD 40533 and 5 U01 HD 40474
Havens P, Hazra R, Stephensen C, van Loan M, Rutledge B, Bethel J, Pan C, Liu N, Lujan-Zilbermann J, Mulligan K, and the Adolescent Trials Network (ATN) study 063 team. Vitamin D3 (VITD) Supplementation Decreases Parathyroid Hormone (PTH) in HIV-infected Youth Being Treated with Tenofovir (TDF)-containing Combination Antiretroviral Therapy (cART): a Randomized, Double-blind, Placebo-controlled Multicenter Trial (RCT): Ad. Oral presentation at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, February 27-March 2, 2011. (ATN 063)

5 U01 HD 40533 and 5 U01 HD 40474
Alexander AB, Ott MA, Lally M, Zimet GD, and the ATN. Preventive Misconception and Adolescents' Knowledge about HIV Vaccine Trials. Oral presentation at the 2011 Society for Adolescent Health and Medicine annual meeting in Seattle, Washington, March 29 - April 1, 2011. (ATN 076)

5 U01 HD 40533 and 5 U01 HD 40474
Baheti G, Brundage RC, Kiser JJ, Havens P, Fletcher CV, and the Adolescent Trials Network for HIV/AIDS Interventions. Plasma and Intracellular Population Pharmacokinetics Analysis of Tenofovir in HIV-1 Infected Patients. Poster presentation at the 2011 American Conference on Pharmacometrics (ACoP), April 3-6, 2011, San Diego, CA (ATN 056)

5 U01 HD 40533 and 5 U01 HD 40474
Bruce D, Harper GW, and the Adolescent Trials Network for HIV/AIDS Interventions. Heavy Marijuana Use among Young HIV-Positive Gay and Bisexual Men. Poster presentation at the 2011 Society of Behavioral Medicine Conference, April 27-30, 2011, Washington, D.C. (ATN 070)

5 U01 HD 40533 and 5 U01 HD 40474
Wilson E. Parental support and HIV-related risk behavior among transgender female youth. Oral presentation at the 2011 National Transgender Health Summit, April 8-9, 2011, San Francisco, CA. (ATN 039)

5 U01 HD 40533 and 5 U01 HD 40562
Stines S, Khalili J, Walker BC, Willard N, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. Mobilizing toward Structural Interventions for HIV Prevention. Poster presentation at the 32nd Annual Minority Health Conference, February 25, 2011, webcast. (ATN 040)

5 U01 HD 40533 and 5 U01 HD 40474
Havens PL, Mulligan K, Hazra R, Van Loan MD, Pan CG, Bethel J, Rutledge BN, Kapogiannis BG, Flynn PM, Lujan-Zilbermann J, Kiser JJ, Baker AM, Liu NX, Wilson CM, Stephensen CB and the Adolescent Trials Network (ATN) study 063 team. Safety and efficacy of once-monthly dosing of Vitamin D 3 (50,000 IU) in HIV-infected youth: ATN 063. Oral presentation at the 13th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV, July 14-16, 2011, in Rome Italy. (ATN 063)

5 U01 HD 40533 and 5 U01 HD 40474
Agwu AL, Bethel J, Hightow-Weidman LB, Sleasman JW, Wilson CM, Rudy B, Kapogiannis BG. Substantial Multiclass Transmitted Drug Resistance and Drug-Relevant Polymorphisms Among Treatment-naïve Adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Study. Poster presentation at the 2011 International AIDS Society Meeting, July 17-20, 2011, Rome, Italy. (ATN 061)

5 U01 HD 40533 and 5 U01 HD 40474
Kahn JA, Xu J, Zimet GD, Liu N, Gonin R, Dillard ME, Squires K, and the ATN. Risk Perceptions after Human Papillomavirus Vaccination in HIV-Infected Adolescent and Young Adult Women. Poster presentation at the 27th International Papillomavirus Meeting, September 17-22, 2011, in Berlin, Germany. (ATN 064)

5 U01 HD 40533 and 5 U01 HD 40474
Kahn JA, Burk R, Squires K, Kapogiannis B, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson CM, and the ATN. HPV Epidemiology in HIV-Positive Young Women Receiving Their First HPV Vaccination. Poster presentation at the 27th International Papillomavirus Meeting, September 17-22, 2011, in Berlin, Germany. (ATN 064)

5 U01 HD 40533 and 5 U01 HD 40474
Lin A, Castillo M, Gwiazdowski B, and the Adolescent Trials Network for HIV/AIDS Interventions. Enhancing youth-based housing services and HIV prevention through community engagement; A successful model for identifying and implementing structural changes for homeless LGBT adolescents. Roundtable presentation at the 2011 American Public Health Association conference, October 29-November 2, 2011, Washington, D.C. (ATN 040)

5 U01 HD 40533 and 5 U01 HD 40562
Stines S, Khalili J, Walker BC, Willard N, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. Mobilizing toward Structural Interventions for HIV Prevention. Oral presentation at the American Public Health Association Meeting, Oct. 29 – Nov. 2, 2011, Washington, D.C. (ATN 040)

5 U01 HD 40533 and 5 U01 HD 40474
Tanner AE, Philbin M, Duval A, Ellen J, Kapogiannis B, Dunbar E, Fortenberry JD. Linking adolescents infected with HIV into care: The effects of relationships between local health departments and adolescent medicine clinics. Oral presentation at the 2011 American Public Health Association conference, October 29-November 2, 2011, Washington, D.C. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Philbin M, Tanner AE, Duval A, Ellen J, Kapogiannis B, Dunbar E, Fortenberry JD. Models of Linkage to Care for newly diagnosed HIV-positive adolescents within fifteen Adolescent Medicine Clinics in the United States. Oral presentation at the 2011 American Public Health Association conference, October 29-November 2, 2011, Washington, D.C. (ATN 093)

5 U01 HD 40533 and 5 U01 HD 40474
Bruce D, Harper GW, and the Adolescent Trials Network for HIV/AIDS Interventions. Sexual Risk Behavior and Secondary Prevention Beliefs among Young HIV-Positive MSM. Poster presentation at the 2011 American Public Health Association conference, October 29-November 2, 2011, Washington, D.C. (ATN 070)

5 U01 HD 40533 and 5 U01 HD 40474
Robles-Schrader G, Lewis C, Roy J. Hitting the Mark: Using Root Cause Analysis to Identify Structural Changes Aimed at Addressing the HIV Epidemic. Oral presentation at the 2011 US Conference on AIDS Pre-Conference Institute, Chicago, IL, November 9, 2011. (ATN 040)

 

2010

5 U01 HD 40533 and 5 U01 HD 40474
Straub D, Arrington-Sanders R, Harris R, Willard N, Futterman D, Kapogiannis B, Emmanuel P, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. HIV testing of high risk youth: what do we know about those who don’t get tested? Accepted 10/15/09 for poster presentation at the  Annual Meeting of the Society for Adolescent Medicine, April 7-10, 2010, Toronto, Ontario, Canada (ATN 016b)

5 U01 HD 40533 and 5 U01 HD 40474
Freeman P, Cooper-Walker B, Ellen JE, Garofalo R and the Adolescent Trials Network for HIV/AIDS Interventions. YMSM who report using methamphetamine: Recruitment venues and HIV-related risk behavior. Oral presentation at the Annual Meeting of the Society for Adolescent Medicine, April 7-10, 2010, Toronto, Ontario, Canada. (ATN 040-local)

5 U01 HD 40533 and 5 U01 HD 40474
Ventuneac A, Carballo-Diéguez A, Khan J, Zimet G, Leu, Giguere R, Mabragaña, McGowan, and the Adolescent Trials Network for HIV/AIDS Interventions. Use of Telephone and Web-based Technology to Monitor Adherence. Poster presentation at the 2010 International Microbicides Conference, May 22-25, 2010, Pittsburgh, PA. (ATN 062)

5 U01 HD 40533 and 5 U01 HD 40474
Carballo-Diéguez A, Giguere R, Chen B, Dolenzal C, Khan J, Zimet G, Mabragaña M, Lee S, McGowan I, and the Adolescent Trials Network for HIV/AIDS Interventions. Acceptability Lessons Learned in a Phase 1 Microbicide Trial Involving Product Use During Vaginal Intercourse.  Poster presentation at the 2010 International Microbicides Conference, May 22-25, 2010, Pittsburgh, PA. (ATN 062)

5 U01 HD 40533 and 5 U01 HD 40474
McGoy S, Hurd-Sawyer L, and Williams A. Taking it to the Streets-Partying with a Purpose. Oral presentation at the NACCHO Annual 2010 Conference, July 14-16, 2010, Memphis, TN. (ATN 040)

5 U01 HD 40533 and 5 U01 HD 40474
Harper G, Bruce D, Hosek S, Fernandez M, and the Adolescent Trials Network for HIV/AIDS Interventions. Resilience among Gay/Bisexual Male Youth Living with HIV: Implications for Intervention. Oral presentation at the International AIDS Society Convention, July 18-23, 2010, Vienna, Austria. (ATN 070)

5 U01 HD 40533 and 5 U01 HD 40474
Brothers J, Rodriguez, Hosek S, and the Adolescent Trials Network for HIV/AIDS Interventions. A Mixed but Colorful Bag: The Benefits and Challenges of Involving Young HIV-Positive Women in the Design and Development of a Secondary Prevention Intervention. Poster presentation at the International AIDS Society Convention, July 18-23, 2010, Vienna, Austria. (ATN 073)

5 U01 HD 40533 and 5 U01 HD 40474
LoPresto J, Harper G, and the Adolescent Trials Network for HIV/AIDS Interventions. Influences of Social Support and HIV on Gay Identity Development. Poster presentation at the American Psychological Association Annual Convention, August 12-15, 2010, San Diego, CA. (ATN 070)

5 U01 HD 40533 and 5 U01 HD 40474
Harper G, Fernandez M, Jamil O, Hildago M, Torres S, and the Adolescent Trials Network for HIV/AIDS Interventions. An Empirically-Based Transactional Model of Same-Sex Sexual Orientation Identity Development. Poster presentation at the American Psychological Association Annual Convention, August 12-15, 2010, San Diego, CA. (ATN 070)

5 U01 HD 40533 and 5 U01 HD 40474
Harper G, Bruce D, Rogers, and the Adolescent Trials Network for HIV/AIDS Interventions. Attraction, Dating and Sex: Implications for the Sexual Health of Gay/Bisexual Male Youth. Oral presentation at the American Public Health Association Conference, November 6-10, 2010, Denver, CO. (ATN 020)

5 U01 HD 40533 and 5 U01 HD 40474
Lopez B, Gassama M, Bruce D, Spiegel H, Futterman D, and the Adolescent Trials Network for HIV/AIDS Interventions. HIV and STI Rates and Trends among Youth in the Bronx from 2005 to 2008. Poster presentation at the 9th International Conference on Urban Health (ICUH) in New York City, NY, October 27-29, 2010. (ATN 040b)

5 U01 HD 40533 and 5 U01 HD 40474
Camacho M, Jones, Gonzalez, Ellen J, and the ATN, C2P Manhattan. Religious and Spiritual Beliefs Among Black and Latino YMSM -- Implications for Partnerships in HIV Prevention. Oral presentation at the 9th International Conference on Urban Health (ICUH) in New York City, NY, October 27-29, 2010. (ATN 040b)

5 U01 HD 40533 and 5 U01 HD 40474
Lally M, Goldsworthy, Sniecinski K, and Zimet G. Development of Tools to Reduce Preventive Misconception in HIV Vaccine Trials among Adolescents. Poster presentation at the 2010 AIDS Vaccine Conference in Atlanta, GA, September 28 - October 1, 2010. (ATN 076)

5 U01 HD 40533 and 5 U01 HD 40474
Maxwell D, Allota, Jones, Camacho M, Ellen J, and the ATN, C2P Manhattan. Outspoken -- Using Media and Community Partnerships to Adapt the CDC DEBI Community PROMISE. Oral presentation at a special session at the 9th International Conference on Urban Health (ICUH) in New York City, NY, October 27-29, 2010. (ATN 041)

5 U01 HD 40533 and 5 U01 HD 40474
Hosek S, Harper G, Lemos D, and the ATN. Project ACCEPT: A Behavioral Intervention to Improve Engagement in Care for HIV-Positive Youth. Poster presentation at the 2010 National Summit on HIV Diagnosis, Prevention and Access to Care in National Harbor, MD, November 17-19, 2010. (ATN 068)

5 U01 HD 40533 and 5 U01 HD 40474
Mulligan K, Havens P, and the ATN. Evidence of Renal Tubular Impairment and Increased Bone Turnover in HIV-infected Adolescents and Young Adults on Tenofovir-containing cART: Baseline Results of the Adolescent Trials Network (ATN) Study 063.  Oral presentation at the 12th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV, November 4-6, 2010, London, UK. (ATN 063)

5 U01 HD 40533 and 5 U01 HD 40562
Stines S, Khalili J, Walker BC, Willard N, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. Mobilizing toward Structural Interventions for HIV Prevention. Poster presentation at the 2010 HIV Prevention Leadership Summit in Washington, DC, December 12-15, 2010. (ATN 040)

5 U01 HD 40533 and 5 U01 HD 40562
Stines S, Khalili J, Walker BC, Willard N, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. Mobilizing toward Structural Interventions for HIV Prevention. Submitted 11/04/10. Poster presentation at the International Conference on STIGMA in Washington, DC, December 1, 2010. (ATN 040)

 

2009

5 U01 HD 40533 and 5 U01 HD 40474
Mulligan K, Monte D, Harris R, Stosze S, Emmanuel P, Hardin D, Kapogiannis B, Worrell C, Wilson C, Aldrovandi GM. Metabolic abnormalities in young behaviorally HIV-infected women: preliminary results for Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) – ATN 021. Poster presentation at the Conference on Retroviruses and Opportunistic Infections, February 8-11, 2009, Montreal, Canada.  Abstract No. 977 (ATN 021a)

5 U01 HD 40533 and 5 U01 HD 40474
Jennings JM, Ellen JM, Deeds BG, Harris DR, Muenz LR, Barnes W, Lee S, Auerswald CL, and the Adolescent Medicine Trials Network for HIV / AIDS Interventions. Recent Partner-Specific HIV Transmission Risk for Youth Living with HIV. Poster presentation at the Annual Meeting of the Society for Adolescent Medicine, March 25-28, 2009, Los Angeles, California. Abstract No. 29 (ATN 016b)

5 U01 HD 40533 and 5 U01 HD 40474
Flynn PM, Rudy B, Wilson C, Kapogiannis B, Worrell C, Bethel J, Monte D, and Cunningham CK. Improving Seroresponse to Hepatitis B Vaccination in HIV-Infected Adolescents: ATN 024. Poster presentation at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, 2009, Cape Town, South Africa.  (ATN 024)

5 U01 HD 40533 and 5 U01 HD 40474
Flynn PM, Rudy B, Wilson C, Kapogiannis B, Worrell C, Bethel J, Monte D, and Cunningham CK. Improving Seroresponse to Hepatitis B Vaccination in HIV-Infected Adolescents: ATN 024. Poster presentation at the 1st International Workshop on HIV Pediatrics, July 17-18, 2009, Cape Town, South Africa. (ATN 024)

5 U01 HD 40533 and 5 U01 HD 40474
Lemos D, Hosek SG, Harper GW and the Adolescent Medicine Trials Network for HIV / AIDS Interventions. Peer Facilitator Involvement with Youth Newly Diagnosed with HIV: Lessons Learned from Project ACCEPT. Oral presentation at the CDC National HIV Prevention Conference, August 23-26, 2009, Atlanta Georgia. Abstract No. 233 (ATN 068)

5 U01 HD 40533 and 5 U01 HD 40474
Castillo M, Palmer B, Ellen J, Willard N, The Adolescent Trials Network, Connect to Protect® Philadelphia. Implementing HIV Prevention, Awareness, and Testing in the Ballroom Community.  Poster presentation at the American Public Health Association Annual Meeting, November 7-11, 2009, Philadelphia, PA. (ATN 041)

5 U01 HD 40533 and 5 U01 HD 40474
Castillo M, Lin A, Ellen J, Willard N, The Adolescent Trials Network, Connect to Protect® Philadelphia. HIV Prevention for Housing Insecure LGBT Youth.  Poster presentation at the American Public Health Association Annual Meeting, November 7-11, 2009, Philadelphia, PA. (ATN 041)

5 U01 HD 40533 and 5 U01 HD 40474
Bruce D, Harper GW and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Operating without a safety net: Gay male adolescents' responses to marginalization and migration and implications for theory of syndemic production of health disparities. Oral presentation at the American Public Health Association Annual Meeting, November 7-11, 2009, Philadelphia, PA. (ATN 070)

5 U01 HD 40533 and 5 U01 HD 40474
Harper GW, Timmons A, LoPresto J, Ackron T, Rood B, Bruce D and the ATN 070 Protocol Team. Drugs, Sex, Condoms: Cultural Messages Influencing HIV+ Black Gay/Bisexual Youth. Oral presentation at the American Public Health Association Annual Meeting, November 7-11, 2009, Philadelphia, PA. (ATN 070)

5 U01 HD 40533 and 5 U01 HD 40474
Freeman PF, Robles-Schrader GM, and Ellen J. Systems changes to promote sexual literacy. Oral presentation at the 50th Annual Meeting for the Society for the Scientific Study of Sexuality, November 5-8, 2009, Puerto Vallarta, Jalisco, Mexico. (ATN 040)

5 U01 HD 40533 and 5 U01 HD 40474
Brennan J, Stauffer A and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Syndemic Theory and HIV-related Risk Among Young Transgender women: The Role of Multiple, Co-Occurring Health Problems. Oral presentation at the 50th Annual Meeting for the Society for the Scientific Study of Sexuality, November 5-8, 2009, Puerto Vallarta, Jalisco, Mexico. (ATN 039)

5 U01 HD 40533 and 5 U01 HD 40474
Lemos D, Hosek SG and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Process Evaluation of a Gender-Specific Sexuality Session for Youth Recently Diagnosed with HIV. Oral presentation at the 50th Annual Meeting for the Society for the Scientific Study of Sexuality, November 5-8, 2009, Puerto Vallarta, Jalisco, Mexico. (ATN 068)

5 U01 HD 40533 and 5 U01 HD 40474
Brothers J, Hosek SG and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. From Their Mouths to Our Ears:  What Young HIV+ Women Perceive to be Their Biggest Challenges and What They Want from Targeted Interventions. Oral presentation at the 50th Annual Meeting for the Society for the Scientific Study of Sexuality, November 5-8, 2009, Puerto Vallarta, Jalisco, Mexico. (ATN 073)

 

2008

5 U01 HD 40533 and 5 U01 HD 40474
Rudy B, Sleasman J. Kapogiannis B, Wilson C, Bethel J, Cunningham C, and the Adolescent Trials Network for HIV/AIDS Interventions 015 Study Team. Short Cycle Therapy in Adolescents Following Continuous Therapy with Established Viral Suppression:  The Effect on Viral Load Suppression. Poster presentation at the 15th Conference on Retroviruses and Opportunistic Infections, Feb. 3-6, 2008, Boston, Massachusetts. Abstract # 580. (ATN 015)

5 U01 HD 40533 and 5 U01 HD 40474
Cunningham CK, Rudy BJ, Bethel J, Kapogiannis BG, Ahmad S, Wilson CM, Flynn PM. Seroresponse to 2-Dose Hepatitis B Immunization among Youth at Adolescent Clinics (ATN). Poster presentation at the Pediatric Academic Societies and Asian Society for Pediatric Research Joint Annual Meeting, May 3-6, 2008, Honolulu, Hawaii. (ATN 025)

5 U01 HD 40533 and 5 U01 HD 40474
Gilliam PP, Ellen JM, Leonard L, Kinsman S, and Straub DM. Transitional Care for Adolescents with HIV. Poster presentation at the Annual Meeting of the Society for Adolescent Medicine, March 26-29, 2008, Greensboro, North Carolina. (PCS 060)

4 R01 DA 014706
Finger JL, Clum G, Trent M. Desire for Pregnancy and Risk Behavior in Young HIV+ Women. Oral presentation at the Annual Meeting of the Society for Adolescent Medicine, March 26-29, 2008, Greensboro, North Carolina. (ATN 009)

5 U01 HD 40533 and 5 U01 HD 40474
Sill A, Constantine N, Wilson C, Peralta L, The Adolescent Trials Network for HIV/AIDS Interventions. Demographic, Clinical, Risk Profiles and Rates of Recent Infection among HIV-Infected Adolescents and Young Adults.  CD-ROM publication from the XVII International AIDS Conference, August 3-8, 2008, Mexico City, Mexico.  Abstract No. CDC0141.  (ATN 022)

5 U01 HD 40533 and 5 U01 HD 40474
Lemos D, Hosek S, Adolescent Trials Network. Disclosing for the First Time: Thoughts and Experiences of Youth Living with HIV. Poster presentation at the XVII International AIDS Conference, August 3-8, 2008, Mexico City, Mexico. Abstract No. MOPE0179   (ATN 055)

5 U01 HD 40533 and 5 U01 HD 40474
Serrano P, Harper GW, Fernandez MI. Internet's Role in Sexual Health of Gay/Bisexual/Questioning Adolescents. Oral presentation at the Annual American Public Health Association Meeting October 25-29, 2008, San Diego, California. (ATN 020)

 

2007

5 U01 HD 40533 and 5 U01 HD 40474
Hidalgo MA. Ecological factors influencing the condom use and non-use behaviors of gay, bisexual and questioning young men. Poster presentation at APA National Multicultural Conference and Summit, January 24-26, 2007, Seattle, WA.  (ATN 020)

5 U01 HD 40533 and 5 U01 HD 40474
Naar-King S, Lam P, Wright K, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Recruitment and retention in healthy choices: a motivational intervention (MI) for HIV+ youth. Poster presentation at the Annual Meeting of the Society for Adolescent Medicine, March 28-31, 2007, Denver, Colorado. Abstract No. 49.  (ATN 004)

5 U01 HD 40533 and 5 U01 HD 40474
Kiser JJ, Fletcher CV, Flynn P, Cunningham CK, Wilson CM, Kapogiannis B, Major-Wilson H, Viani RM, Muenz L, Harris B, Havens PL. and the Adolescent Trials Network. Pharmacokinetics (PK) of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate (TDF) and Atazanavir/Ritonavir (ATV/RTV) in Adolescents and Young Adults with HIV Infection - Study ATN 056. Oral presentation at the 8th International Workshop on Clinical Pharmacology of HIV Therapy in Budapest, Hungary April 16-18, 2007. Abstract No. 12. (ATN 056)

5 U01 HD 40533 and 5 U01 HD 40474
Jamil OB. How They Knew: Contexts of Awareness of Sexual Identity for GBQ Male Youth Oral presentation at the 3rd Annual International Congress of Qualitative Inquiry, May 2-5, 2007, Champaign-Urbana, Illinois. (ATN 020)

5 U01 HD 40533 and 5 U01 HD 40474
Harper GW, Jamil OB, Hidalgo MA and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Gay/Bisexual/Questioning Youth of Color: Sexual Identity and the Internet. Oral presentation at the 11th Biennial Conference of the Society for Community Research and Action, June 7-10, 2007, Pasadena, California. (ATN 020)

5 U01 HD 40533 and 5 U01 HD 40474 Fernández MI, Jamil OB, Warren JC, Hidalgo MA, Harper GW, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Culture, Context, and Development: HIV Prevention for Gay/Bisexual/Questioning Youth. Symposium presentation at the 11th Biennial Conference of the Society for Community Research and Action, June 7-10, 2007, Pasadena, California. (ATN 020)

5 U01 HD 40533 and 5 U01 HD 40474
Harper GW, Fernández MI, Jamil OB, Wilson BDM, Torres RS, Warren JC, Hidalgo MA, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Promoting Resilience among Gay, Bisexual, and Questioning Male Youth. Symposium presentation at the 115th Annual Convention of the American Psychological Association, August 17-20, 2007, San Francisco, California. (ATN 020)

5 U01 HD 40533 and 5 U01 HD 40474
Lee S, Kapogiannis B, Cunningham C, Flynn P, Rudy D, Bethel J, Serchuck L, Ahmad S, Tucker D, Abdalian SE, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Comprehension of a simplified assent/consent form in a vaccine trial for youth. Poster presentation at the AIDS Vaccine 2007 Conference, August 20-23, 2007, Seattle, Washington.  (ATN 025b)

5 U01 HD 40533 and 5 U01 HD 40474
Lemos D, Hosek SG, Harper GW. Provider Perceptions of the Challenges Faced by Youth Newly Diagnosed with HIV. Poster presentation at the Annual American Public Health Association Meeting, November 3-7, 2007, Washington, DC. (ATN 055)

5 U01 HD 40533 and 5 U01 HD 40474
Neubauer, LC, Harper GW, Bangi AK, and Ellen J. The Quality Assurance Team (QAT): Developing Mechanisms for Multiple Voices to be heard in Transdisciplinary Multi-Site Community Research. Oral presentation at the American Evaluation Association (AEA) Conference, November 7-10, 2007, Baltimore, Maryland. (ATN 016a)

5 U01 HD 40533 and 5 U01 HD 40474
Lemos D. Hosek SG, Harper GW. Sources of Support for Youth during the First year Following an HIV Diagnosis. Oral presentation at the 2007 National HIV Prevention Conference, December 2-5, 2007. Atlanta, GA (ATN 055)

 

2006

5 U01 HD 40533 and 5 U01 HD 40474
Viani R, Peralta L, Aldrovandi G, Kapogiannis BG, Mitchell R, Spector SA, Lie Y, Weidler J, Bates M, Wilson C. Prevalence of primary HIV-1 drug resistance among recently infected adolescents; A multicenter Adolescent Trials Network Study: ATN 029. Oral presentation for Conference on Retroviruses and Opportunistic Infections, February 5-8, 2006, Denver, CO. Abstract no. 21. (ATN 029)

5 U01 HD 40584
Deeds BG, Straub DM, Willard N, Castor J, Ellen J, Peralta L and the Adolescent Trials Network for HIV/AIDS Interventions. Fertile Ground: The Role of a Community ASSET Assessment in 15 Community-Researcher Partnerships Promoting Adolescent Health. Platform presentation at Society for Adolescent Medicine Meeting, March 22-25, 2006, Boston, MA.  (ATN 016a)

5 U01 HD 40497
Straub DM, Deeds BG, Willard N, Castor J, Peralta L, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. The Partner Selection Process: A Case Study of 15 Community-Researcher Partnerships Promoting Adolescent Health. Poster presentation at the Society for Adolescent Medicine Meeting, March 22-25, 2006, Boston, MA. Abstract no. 50.  (ATN 016a)

5 U01 HD 40533 and 5 U01 HD 40474
Torres RS. Relationships that Matter: Exploring Mentoring Relationships in the Lives of GBQ Male Youth. Poster Presentation at the Society for Research on Adolescence (SRA) 2006 Biennial Meeting, March 23-26, San Francisco, CA.  (ATN 020)

5 U01 HD 40533 and 5 U01 HD 40474
Harper GW, Fernandez I, Gehle J, Rodriguez A, Wilson BDM, Hidalgo MA, Torres RS, Jamil OB. Hear Me OUT!: Voices of Gay, Bisexual, and Questioning Youth. Symposium presentation at the 2nd International Congress of Qualitative Inquiry, May 4-6, 2006, Champaign-Urbana, IL.  (ATN 020)

5 U01 HD 40533 and 5 U01 HD 40474
Peralta L, Sill A, Kreisel K, Griffin-Deeds B, Constantine N. Development of a less-sensitive assay using oral fluid to detect recent HIV-1 infection: A multicenter study of the Adolescent Trials Network. Abstract Book and CD Rom: XVI International AIDS Conference, August 13-18, 2006 Toronto, Ontario, Canada. Abstract no. CDC0246.  (ATN 022)

5 U01 HD 40533 and 5 U01 HD 40474
Peralta L, Gorle R, Flores L, Colocho E, Boyer C, Griffin-Deeds B. Hepatitis B Vaccine Clinical Trial for Adolescents: A Model to Evaluate Strategies to Enroll Adolescents in Future HIV Vaccine Clinical Trials. Poster presentation at AIDS Vaccine 2006 Conference, August 29-September 1, 2006, Amsterdam, Netherlands. Abstract no. 400.00. (ATN 025b)

5 U01 HD 40533 and 5 U01 HD 40474
Bansal A, Yue L, Conway J, Yusim K, Kaslow RA, Wilson CM, Kappes J, Goepfert PA. Amino Acid Variation of Targeted HIV -1 Specific CD8+ T -Cell Epitopes Correlates with HLA Class I Disease Association. Oral presentation at the AIDS Vaccine 2006 Conference, August 29-September 1, 2006, Amsterdam, the Netherlands.  (ATN 026)

5 U01 HD 40533 and 5 U01 HD 40474
Wilson EC, Belzer M, Garofalo R, Iverson E, Martinez M, Herrick A and the Adolescent Trials Network for HIV/AIDS Interventions. Male-to-Female (MTF) transgender youth and HIV: a roundtable discussion of HIV risk within this vulnerable youth community. Poster presentation at American Public Health Association Annual Meeting, November 4-8, 2006, Boston, MA. Abstract #129567.  (ATN 039) 

5 U01 HD 40533 and 5 U01 HD 40474
Ziff MA, Willard N, Harper G, Bangi A, Johnson JK, Ellen JM. Longitudinal Assessments of Perceived Coalition Functioning in the Connect to Protect® Partnerships for Youth Prevention Interventions Study. Poster presentation at the 5th annual International Conference on Urban Health (ICUH), October 25-28, 2006 Amsterdam, the Netherlands.  (ATN 016b)

 

2005

5 U01 HD 40533 and 5 U01 HD 40474
Constantine N, Peralta L, Sill A, Kreisel K, Griffin B. Development of an oral fluid assay capable of differentiating recent from established HIV infection. Poster presentation at the CDC HIV Diagnostics Conference, February 28 - March 1, 2005, Orlando, Florida.  (ATN 022) 

 

2004

5 U01 HD 40533 and 5 U01 HD 40474
Constantine N, Peralta L, Sill A, Kreisel K, Griffin B, Wilson C, Rogers A. Development of an oral fluid assay capable of differentiating recent from established HIV infection. Oral presentation at Satellite Meeting, “Testing Options for Estimating HIV Incidence,” prior to the XV International AIDS Conference, July 11, 2004, Bangkok, Thailand.   (ATN 022)

5 U01 HD 40506
Geanuracos C, Schroeder S, Perez M. Applying GIS Mapping in Program Planning and Community Relations for Youth HIV Prevention. Skill building workshop at the Global Health Council's 31st Annual Conference, Youth and Health: Generation on the Edge, June 1-4, 2004, Washington, D.C.  (ATN 016a) 

5 U01 HD 40490
Rivera C, Febo I, Blasini I Ibrahim R. Epidemiological Profile of Youth 12 to 24 Year Old in Puerto Rico and Mapping Data of HIV High Risk Geographic Areas to Implement Prevention Interventions. Oral presentation at the Second Puerto Rican Conference on Public Health, September 1-3, 2004, San Juan, Puerto Rico.  (ATN 016a) 

 

 

Accepted Abstracts

5 U01 HD 40533 and 5 U01 HD 40474
Neilan AM, Bulteel A, Freedberg K, Hosek S, Landovitz RJ, Walensky RP, Wilson CM, Ciaranello AL, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Cost-effectiveness of regular HIV screening for young men who have sex with men. Accepted as a poster presentation to the CROI Conference, Boston, MA, March 4-7, 2018.  (ATN 110)

5 U01 HD 40533 and 5 U01 HD 40474
Neilan AM, Bulteel A, Freedberg K, Hosek S, Landovitz RJ, Walensky RP, Wilson CM, Ciaranello AL, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Cost-effectiveness of regular HIV screening for young men who have sex with men. Accepted as an oral presentation to the SAHM Conference, Seattle, WA, March 14-17, 2018.  (ATN 110)

5 U01 HD 40533 and 5 U01 HD 40474
Gamarel KE, Nelson KM, Stephenson R, Santiago-Rivera OJ, Chiaramonte D, Miller RL, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Forecasted HIV stigma and delays in regular HIV testing behaviors among sexually active young men who have sex with men and transgender women. In J. Rendina (Chair), Translational research on the role of forecasted HIV stigma in the context of HIV prevention. Symposium to be presented at the 39th Annual Meeting and Scientific Sessions of the Society of Behavioral Medicine, New Orleans, LA, April 11-14, 2018. (ATN 095-105)

 

PUBLISHED SCIENTIFIC PAPERS

 

2017

5 U01 HD 40533 and 5 U01 HD 40474 
Hosek S, Rudy B, Landovitz R, Kapogiannis B, Rutledge B, Liu N, Brothers J, Mulligan K, Lally M, Zimet G, Mayer K, Rooney J, Wilson CM and the Adolescent  Medicine Trials Network for HIV/AIDS Interventions. An HIV Pre-Exposure Prophylaxis (PrEP) Demonstration Project and Safety Study for Young MSM (ATN 110). J Acquir Immune Defic Syndr, 2017 Jan 1;74(1):21-29. (ATN 110) PMID 27632233 PMCID 5140725 [Available on 2018-01-01]

5 U01 HD 40533 and 5 U01 HD 40474
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Liu N, Wilson CM, Hazra R, Hosek SG, Anderson PL, Seifert SM, Kapogiannis BG, Mulligan K, and the Adolescent Medicine Trials Network. Decline in Bone Mass with Tenofovir Disoproxil Fumarate/Emtricitabine is Associated with Hormonal Changes in the Absence of Renal Impairment When Used by HIV Uninfected Adolescent Boys and Young Men for HIV Pre-Exposure Prophylaxis. CID, 2017 Feb 1;64(3):317-325. (ATN 117) PMID 28013265 PMC Journal – In Process

5 U01 HD 40533 and 5 U01 HD 40474
Boyer C, Greenberg L, Chutuape K, Walker B, Monte D, Kirk J, Ellen J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Exchange of Sex for Drugs or Money Among Urban Adolescents and Young Adults: An Examination of Sociodemographic Factors, HIV-Related Risk, and Community Context. J Community Health, 2017 Feb;42(1):90-100. (ATN 095/105) PMID 27498094 PMCID 5253104 [Available on 2018-02-01]

5 U01 HD 40533 and 5 U01 HD 40474
van den Berg J, Fernandez MI, Fava J, Rudy B, Wilson P, and the Adolescent Trials Network for HIV/AIDS Interventions. Using Syndemics Theory to Investigate Risk and Protective Factors Associated with Condomless Sex Among Youth Living with HIV in 17 U.S. Cities. AIDS Behav, 2017 Mar;21(3):833-844. (ATN 086-106) PMID 27624727 PMCID 5624520
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624520/

5 U01 HD 40533 and 5 U01 HD 40474
Philbin MM, Tanner AE, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Medicine Trials Network. Understanding care linkage and engagement across 15 Adolescent clinics: Provider perspectives and implications for newly HIV-infected youth. AIDS Educ Prevent. 2017: 29(2) 93-103. (ATN 093) PMID 28467164  PMCID 5441680
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441680/

5 U01 HD 40533 and 5 U01 HD 40474
Kahn J, Xu J, Kapogiannis B., Sleasman J, and the Adolescent Trials Network for HIV/AIDS Interventions. Antibody responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay. J Acquir Immune Defic Syndr, 2017 Jun 1;75(2):241-245. (ATN 064) PMID 28291048 PMCID 5429191 [Available on 2018-06-01]

5 U01 HD 40533 and 5 U01 HD 40474
Miller RL, Fortenberry JD, Chiaramonte D, Lindeman P, Boyer CB, Chutuape K, Cooper-Walker B, Wilson CW, Kapogiannis B, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions.
Evaluating Testing Strategies for Identifying Youths With HIV Infection and Linking Youths to Biomedical and Other Prevention Services. JAMA Pediatr, 2017 Jun 1;171(6):532-537. (C2TaP) PMID 28418524 PMC Journal [available on 2018-06-01]

5 U01 HD 40533 and 5 U01 HD 40474 
Gamarel KE, Nelson KM, Brown L, Fernandez MI, Bruce D, Nichols S, and the Adolescent  Medicine Trials Network for HIV/AIDS Interventions. The usefulness of the CRAFFT in screening for drug and alcohol use among youth living with HIV. AIDS Behav, 2017 Jul;21(7):1868-1877. (ATN 086-106) PMID 27981399 PMCID 5472507

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472507/

5 U01 HD 40533, 5 U01 HD 40474, and 3 U01 HD 040533-09S1 
Fortenberry JD, Koenig LJ, Kapogiannis BG, Jeffries CL, Ellen JM, Wilson CM, and the Adolescent  Medicine Trials Network for HIV/AIDS Interventions. Implementation of an Integrated Approach to the National HIV/AIDS Strategy for Improving Human Immunodeficiency Virus Care for Youths. JAMA Pediatr, 2017 Jul 1;171(7):687-693. (ATN 128) PMID 28531268  PMC – In Process

5 U01 HD 40533 and 5 U01 HD 40474
Philbin MM, Tanner AE, Chambers B, Ma A, Ware S, Lee S, Fortenberry JD, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Transitioning HIV-infected youth to adult care at 14 clinics across the United States: Using adolescent and adult providers' insights to create multi-level solutions to address transition barriers. AIDS Care, 2017 Oct;29(10):1227-1234. (ATN 135) PMID 28599596 PMCID 5573205 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573205/

5 U01 HD 40533 and 5 U01 HD 40474
Miller RL, Reed SJ, Chiaramonte D, Acevedo-Polakovich I, Strzyzykowski T, Spring H, Chutuape K, Cooper-Walker B, Boyer CB, Ellen J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Structural and community change outcomes of the Connect-to-Protect Coalitions: Trials and triumphs securing youth access to HIV prevention, testing, and medical care. Am J Community Psychol, 2017 Sep;60(1-2):199-214. (ATN 095/105) PMID 28851064

5 U01 HD 40533 and 5 U01 HD 40474
Philbin MM, Tanner AE, Chambers BD, Ma A, Ware S, Kinnard EN, Lee S, Fortenberry JD, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. How adolescent and adult HIV providers define and approach HIV-infected youths’ successful transition to adult care in the United States. AIDS Patient Care STD, 2017 Oct;31(10):421-427. (ATN 135) PMID 28981334 PMC Journal – In Process

5 U01 HD 40533 and 5 U01 HD 40474
Tanner AE, Philbin MM, Ma A, Chambers B, Nichols S, Lee S, Ware S, Fortenberry JD, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Adolescent to Adult HIV Healthcare Transition from the Perspective of Adult Providers across 14 Cities in the United States. J Adolesc Health, 2017 Oct;61(4):434-439. (ATN 135) PMID 28754584 PMC Publisher – In Process

5 U01 HD 40533 and 5 U01 HD 40474
Hosek SG, Landovitz RJ, Kapogiannis BG, Siberry GK, Rudy B, Rutledge B, Liu N, Harris R, Mulligan K, Zimet GD, Mayer K, Anderson P, Kiser JJ, Lally M, Brothers J, Bojan K, Rooney J, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States. JAMA Pediatr,
2017 Nov;171(11):1063-1071 (ATN 113) PMID 28873128

5 U01 HD 40533 and 5 U01 HD 40474
Kowalczyk Mullins TL, Zimet, G, Lally, M, Xu J, Thornton S, Kahn JA, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. HIV Care Providers’ Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis (PrEP) to At-Risk Adolescents and Adults. AIDS Patient Care STD, 2017 Dec;31(12):504-516. (ATN 111) PMID 29211514

5 U01 HD 40533 and 5 U01 HD 40474
Reisner SL, Jadwin-Cakmak L, White Hughto JM, Martinez M, Salomon L, Harper GW, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Characterizing the HIV Prevention and Care Continua among U.S. Transgender Youth. AIDS Behav, 2017 Dec: 21:3312-3327 (ATN 130) PMID 29138982

5 U01 HD 40533 and 5 U01 HD 40474
Knopf AS, Liu N, Kapogiannis B, Zimet Z, Fortenberry JD, Hosek S, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Minors’ and young adults’ experiences of the research consent process in a Phase II safety study of pre-exposure prophylaxis for HIV.
J Adolesc Health, 2017 Dec 61(6);747-754. (ATN 137) PMID 28967541 PMCID PMC5701834 [Available on 2018-12-01]

5 U01 HD 40533 and 5 U01 HD 40474
Wilson P, Cherenack E, Jadwin-Cakmak L, Harper G, and the Adolescent Trials Network for HIV/AIDS Interventions. Selection and Evaluation of Media for Behavioral Health Interventions Employing Critical Media Analysis. Health Promot Pract, 2018 Jan;19 (1):145-156. (ATN 090-104) PMID 28627319

5 U01 HD 40533 and 5 U01 HD 40474
van den Berg JJ, Javanbakht M, Gorbach PM, Rudy BJ, Westfall AO, Wilson CM, Lally MA, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Partner Notification for Youth Living with HIV in 14 Cities in the United States. J Acquir Immune Defic Syndr, 2018 Jan:77(1):46-52. (ATN 125) NIHMS 909851

5 U01 HD 40533 and 5 U01 HD 40474
Lally MA, van den Berg JJ, Westfall AO, Rudy BJ, Hosek S, Fortenberry JD, Monte D, Tanney MR, McFarland EJ, Xu J, Kapogiannis BG, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. HIV Continuum of Care for Youth in the United States. J Acquir Immune Defic Syndr, 2018 Jan:77(1):110-117. (ATN 125) NIHMS 909848

 

2016

5 U01 HD 40533 and 5 U01 HD 40474
Brown L, Kennard B, Emslie G, Mayes T, Whitley L, Bethel J, Xu J, Thornton S, Tanney M, Hawkins L, Garvie P, Subramaniam GA, Worrell C, Stoff L and the Adolescent Trials Network for HIV/AIDS Interventions. Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults living with HIV: A controlled trial. J Acquir Immune Defic Syndr, 2016 Jan;71(1):38-46. (ATN 080) PMID 26761270 PMCID 4712723
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712723/

5 U01 HD 40533 and 5 U01 HD 40474 
Miller R, Janulis P, Reed S, Harper G, Ellen J, Boyer C, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Creating youth-supportive communities: Outcomes from the Connect-to Protect® (C2P) structural change approach to youth HIV prevention. J Youth Adolesc, 2016 Feb;45(2):301-15. (ATN 040b) PMID 26534775 PMCID 4714586
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714586/

5 U01 HD 40533 and 5 U01 HD 40474
Wilson P, Kahana S, Fernandez MI, Harper G, Mayer K, Wilson C, Hightow-Weidman L, and the Adolescent Trials Network for HIV/AIDS Interventions. Sexual Risk Behavior among Virologically Detectable HIV-Positive Young Men Who Have Sex With Men. JAMA Pediatrics, 2016;170(2):125-131. (ATN 086-106) PMID 26641367 PMCID 4821589 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821589/

5 U01 HD 40533, 5 U01 HD 40474, and 5 U01 HD32842
Kapogiannis BG, Leister E, Siberry G, Van Dyke R, Rudy B, Flynn P, and Williams P. Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth. AIDS, 2016 Mar 27;30(6):889-898. (ATN 119) PMID 26959353 PMCID 4785818
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785818/

5 U01 HD 40533 and 5 U01 HD 40474
Nichols S, Bethel J, Kapogiannis B, Woods S, Patton E. D., Ren W, Thornton S, Major-Wilson H, Puga A, Sleasman J, Rudy B, Wilson C, Garvie P, and the Adolescent Trials Network for HIV/AIDS Interventions. Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV. J Neurovirol, 2016 Apr;22(2):218-30. (ATN 071) PMID 26463526 PMCID 4781894
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781894/

5 U01 HD 40533 and 5 U01 HD 40474
Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MI, Rubin D and the Adolescent Trials Network for HIV/AIDS Interventions. Behavioral and Health Outcomes for HIV+ Young Transgender Women (YTW) Linked to and Engaged in Medical Care. LGBT Health, 2016 Apr;3(2):162-7. (ATN 086-106) PMID 26789394 PMCID 4723288
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723288/

5 U01 HD 40533 and 5 U01 HD 40474
Kahana S, Jenkins R, Douglas B, Fernandez MI, Hightow-Weidman L, Bauermeister J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Structural Determinants of Antiretroviral Therapy Use, HIV Care Attendance, and Viral Suppression among Adolescents and Young Adults Living with HIV. PLOS One, 2016 Apr 1;11(4):e0151106. (ATN 086-106) PMID 27035905
PMCID 4817971
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817971/

5 U01 HD 40533 and 5 U01 HD 40474
Brothers J, Hotton A, Hosek S, Fernandez MI, Harper G and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Young Women Living with HIV: Outcomes from a Targeted Secondary Prevention Empowerment Pilot Trial. AIDS Patient Care STDs, 2016 May;30(5):229-35.  (ATN 089) PMID 27158851 PMCID 4870604
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870604/pdf/apc.2015.0294.pdf

5 U01 HD 40533 and 5 U01 HD 40474
Boyer CB, Walker BC, Chutuape KS, Roy JR, Fortenberry DJ, and the Adolescent Trials Network for HIV/AIDS Interventions. Creating Systems Change to Support Goals for HIV Continuum of Care: The Role of Community Coalitions to Reduce Structural Barriers for Adolescents and Young Adults. J HIVAIDS Soc Serv, 2016; 15(2): 158-179. (ATN 095-105-116) PMCID 4880364
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880364/

5 U01 HD 40533 and 5 U01 HD 40474 
Ruan A, Tobin NH, Mulligan K, Li F, Sleasman J, Aldrovandi GM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Macrophage Activation in HIV-infected Adolescent Males Contributes to Differential None Loss by Sex: Adolescent Trials Network Study 021. J Acquir Immune Defic Syndr, 2016 Aug 1;72(4):372-5. (ATN 021) PMID 26885808 PMCID 4925249
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925249/

5 U01 HD 40533 and 5 U01 HD 40474
Philbin M, Tanner AE, DuVal A, Ellen J, Xu J, Kapogiannis B, Bethel J, Fortenberry D, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. HIV testing, care referral and linkage to care intervals affect time to engagement in care for newly diagnosed HIV-infected adolescents in fifteen adolescent medicine clinics in the United States.  J Acquir Immune Defic Syndr, 2016 Jun 1;72(2):222-9.  (ATN 093) PMID 26885804 PMCID 4867127
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867127/

5 U01 HD 40533 and 5 U01 HD 40474 
Mullins TL, Zimet G, Lally M., Kahn JA and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Adolescent Human Immunodeficiency Virus Care Providers’ Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth. AIDS Patient Care STDs, 2016 Jul;30(7):339-48. (ATN 111) PMID 27410497 PMCID 4948218
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948218/

5 U01 HD 40533 and 5 U01 HD 40474
Cherenack EM, Wilson PA, Kreuzman A, Price G, and the Adolescent Trials Network for HIV/AIDS Interventions. The Feasibility and Acceptability of Using Technology-Based Daily Diaries with HIV-Infected Young Men who have Sex with Men: A Comparison of Internet and Voice Modalities. AIDS Behav, 2016 Aug;20(8):1744-53. (ATN 112) PMID 26837629 PMCID 4945448
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945448/

5 U01 HD 40533 and 5 U01 HD 40474
Gross I, Hosek S, Richards M, Fernandez MI, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Predictors and Profiles of Antiretroviral Therapy Adherence among African-American Adolescents and Young Adult Males Living with HIV. AIDS Patient Care STDs, 2016 Jul;30(7):324-38. (ATN 086-106) PMID 27410496 PMCID 4948258
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948258/

5 U01 HD 40533 and 5 U01 HD 40474
Harper GW, Serrano PA, Bruce D. The Internet’s Multiple Roles in Facilitating the Sexual Orientation Identity Development of Gay/Bisexual Male Adolescents. Am J Mens Health, 2016 Sep;10(5):359-76. (ATN 020) PMID 25585861 PMCID 4824670
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824670/

5 U01 HD 40533 and 5 U01 HD 40474
MacDonell KK, Tiura AJ, Naar-King S, Fernandez MI, and the Adolescent Trials Network for HIV/AIDS Interventions. Predictors of Self-Reported Adherence to Antiretroviral Medication in a Multisite Study of Ethnic and Racial Minority HIV-Positive Youth. J Pediatr Psychol, 2016 May;41(4):419-28. (ATN 086-106) PMID 26498724  PMC Journal – In Process

5 U01 HD 40533 and 5 U01 HD 40474
Kahn J, Rudy B, Xu J, Kapogiannis B, Secord E, Gillison M, and the Adolescent Trials Network for HIV/AIDS Interventions. Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth. J Med Virol, 2016 Nov;88(11):1944-52. (ATN 114) PMID 27096166 PMCID 5008985
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008985/

5 U01 HD 40533 and 5 U01 HD 40474 
Savel C, Mierzwa S, Gorbach P, Souidi S, Lally M, Zimet G, and the Adolescent  Medicine Trials Network for HIV/AIDS Interventions. Avatar Web-Based Self-Report Survey System Technology for Public Health Research: Technical Outcome Results and Lessons Learned. Online J Public Health Inform  2016 Sep 15;8(2):e189. (ATN 123) PMID 28149445  PMCID 5266758
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266758/

5 U01 HD 40533 and 5 U01 HD 40474
Tanner AE, Philbin MM, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Medicine Trials Network. Transitioning HIV-Positive Adolescents to Adult Care: Lessons Learned From Twelve Adolescent Medicine Clinics. J Pediatr Nurs, 2016 Sep-Oct;31(5):537-43. (ATN 093) PMID 27133767 PMCID 5026881
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026881/

5 U01 HD 40533 and 5 U01 HD 40474 
Gamarel KE, Brown L, Kahler CW, Fernandez MI, Bruce D, Nichols S, and the Adolescent  Medicine Trials Network for HIV/AIDS Interventions. Prevalence and correlates of substance use among HIV-infected youth in clinical settings. Drug Alcohol Depend, 2016 Oct 11;169:11-18. (ATN 086-106) PMID 27750182 PMCID 5140709
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140709/

5 U01 HD 40533 and 5 U01 HD 40474
Harper G, Timmons A, Bruce D, Graham L, Wade R, and the Adolescent Trials Network for HIV/AIDS Interventions. Drugs, Sex, and Condoms: Cultural Messages Influencing Young Black Gay and Bisexual Men Living with HIV. Am J Community Psychol, 2016 Dec;58(3-4):463-476 (ATN 070) PMID 27883219 PMCID 5161543 [Available on 2017-12-01]

5 U01 HD 40533 and 5 U01 HD 40474
Castillo-Mancilla J, Seifert S, Campbell K, Coleman S, McAllister K,  Zheng JH, Gardner EM, Liu A, Glidden DV, Grant R, Hosek S, Wilson CM, Bushman LR, MaWhinney S, Anderson PL, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing. Antimicrob Agents Chemother, 2016 Oct 21;60(11):6692-6697. (ATN 110) PMID 27572401 PMCID 5075074
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075074/

 

2015

5 U01 HD 40533 and 5 U01 HD 40474
Kahana SY, Fernandez MI, Wilson PA, Lee S, Bauermeister JA, Wilson CM, Hightow-Weidman LB, the ATN 086 Protocol Team, and the Adolescent Trials Network for HIV/AIDS Interventions. Rates and Correlates of Antiretroviral Therapy Use and Virologic Suppression Among Perinatally and Behaviorally HIV-Infected Youth Linked to Care in the United States. J Acquir Immune Defic Syndr, 2015 Feb; 68(2):169-77. (ATN 086-106) PMID 25590270 PMCID 4312477
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312477/

5 U01 HD 40533 and 5 U01 HD 40474
Saberi P, Mayer K. Vittinghoff E, Naar-King S, and the Adolescent Medicine Trials Network. Correlation between Use of Antiretroviral Adherence Devices by HIV-infected Youth and Plasma HIV RNA and Self-reported Adherence. AIDS Behav, 2015 Jan; 19(1): 93-103. (ATN 086/106) PMID 24879628 PMCID 4250439
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250439/

5 U01 HD 40533 and 5 U01 HD 40474
Hussen SA, Harper GW, Bauermeister J, Hightow-Weidman L, and the Adolescent Trials Network for HIV/AIDS Interventions. Psychosocial influences on engagement in care among HIV-positive young Black gay/bisexual and other men who have sex with men. AIDS Patient Care STDs, 2015 Feb;29(2):77-85. (ATN 070) PMID 25682888 PMCID 4321768
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321768/

5 U01 HD 40533 and 5 U01 HD 40474
Ellen JM, Greenberg L, Willard N, Korelitz J, Kapogiannis BG, Monte D, Boyer CB, Harper GW, Henry-Reid LM, Friedman LB, Gonin R, and the Adolescent Medicine Trials Network. Evaluation of the effect of Human Immunodeficiency Virus-related Structural Interventions. JAMA Pediatr, 2015 Mar 1;169(3):256-63. (ATN 040b)  PMID 25580593 PMCID 4346420
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346420/

5 U01 HD 40533 and 5 U01 HD 40474
Alexander AB, Ott MA, Lally MA, Sniecinski K, Baker A, Zimet GD, and the Adolescent Trials Network for HIV/AIDS Interventions. Adolescent Decision Making about Participation in a Hypothetical HIV Vaccine Trial. Vaccine, 2015 Mar 10;33(11):1331-7. (ATN 076) PMID 25645175 PMCID 4379417

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379417/

5 U01 HD 40533 and 5 U01 HD 40474
Havens PL, Hazra R. Commentary: The Place of Tenofovir Disoproxil Fumarate in Pediatric Antiretroviral Therapy. Pediatr Infect Dis J, 2015 Apr;34(4):406-8. (editorial that highlights ATN 082) PMID 25599283 PMCID 4357556
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357556/

5 U01 HD 40533 and 5 U01 HD 40474
Brown LK, Whitely L, Harper GW, Nichols S, Nieves A, the ATN 086 Protocol Team, and the Adolescent Trials Network for HIV/AIDS Interventions. Psychological Symptoms among 2,032 Youth Living with HIV. AIDS Patient Care STDs, 2015 Apr;29(4):212-219. (ATN 086-106) PMID 25585049 PMCID 4378856
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378856/

5 U01 HD 40533 and 5 U01 HD 40474
Mullins TL, Lally M. Zimet G, Kahn JA and the Adolescent Trials Network for HIV/AIDS Interventions. Clinician Attitudes toward CDC Interim Pre-Exposure Prophylaxis (PrEP) Guidance and Operationalizing PrEP for Adolescents. AIDS Patient Care STDs, 2015 Apr;29(4):193-203. (ATN 111) PMID 25692683 PMCID 4378662
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378662/

5 U01 HD 40533 and 5 U01 HD 40474
Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML, and the Adolescent Medicine Trials Network. Behavioral, Immunologic, and Virologic Correlates of Oral Human Papillomavirus Infection in HIV-Infected Adolescents. Sex Transm Dis, 2015 May;42(5):246-52. (ATN 114) PMID 25868136 PMCID 4396681
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396681/

5U01 HD 40533 and 5U01 HD 40474
Rudy BJ, Kapogiannis BG, Worrell C. Squires K, Bethel J, Li S, Wilson CM, Emmanuel P. Price G, Hudey S, Goodenow M, Sleasman J, and the Adolescent Trials Network for HIV/AIDS Interventions. Immune Reconstitution but Persistent Activation After 48 weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.J Acquir Immune Defic Syndr, 2015 May 1;69(1):52-60. (ATN 061) PMID 25942459 PMCID 4452031
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452031/

5 U01 HD 40533 and 5 U01 HD 40474
Cook SH, Velera P, Wilson PA and the Adolescent Trials Network for HIV/AIDS Interventions. HIV Status Disclosure, Depressive Symptoms, and Sexual Risk Behavior among HIV-Positive Young Men Who Have Sex with Men. J Behav Med, 2015 Jun;38(3):507-17. (ATN 086/106) PMID 25773478 PMCID 4425621
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425621/

5 U01 HD 40533 and 5 U01 HD 40474
Fernandez MI, Huszti HC, Wilson PA, Kahana S, Nichols SL, Gonin R, Xu J, Kapogiannis BG, the ATN 086 Protocol Team, and the Adolescent Medicine Trials Network. Profiles of Risk Among HIV-Infected Youth in Clinic Settings. AIDS Behav, 2015 May;19(5):918-30. (ATN 086) PMID 25117556 PMCID 4326610
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326610/

5 U01 HD 40533 and 5 U01 HD 40474
Belzer M, Mac-Donnell-Kolmodin K, Clark L, Huang J, Olson J, Kahana S, Naar-King S, Sarr M, Thornton S, and the Adolescent Trials Network for HIV/AIDS Interventions. Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Non-adherence to Antiretroviral Therapy. AIDS Patient Care STDs, 2015 Jun;29(6):338-345. (ATN 078) PMID 25928772  PMCID 4516960

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516960/

5 U01 HD 40533 and 5 U01 HD 40474
Boone MR, Cherenack EM, Wilson PA, ATN 086 Protocol Team, and the Adolescent Medicine Trials Network. Self-Efficacy for Sexual Risk Reduction and Partner HIV Status as Correlates of Sexual Risk Behavior among HIV-Positive Adolescent Girls and Women. AIDS Patient Care STDs, 2015 Jun;29(6):346-353. (ATN 086/106) PMID 25856632 PMCID 4512953
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516953/

5 U01 HD 40533 and 5 U01 HD 40474
Bruce D, Kahana S, Bauermeister J, Nichols S, Hightow-Weidman L, Heinze J, Shea J, Fernandez I, and the Adolescent Trials Network for HIV/AIDS Interventions. Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS. Drug Alcohol Depend, 2015 Jun 1;151:173-80. (ATN 086-106) PMID 25858786 PMCID 4447557

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447557/

5 U01 HD 40533 and 5 U01 HD 40474
Gilbert AL, Knopf A, Fortenberry JD, Hosek SG, Kapogiannis BG, Zimet GD, and the Adolescent Trials Network for HIV/AIDS Interventions. Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research. J Adolesc Health, 2015 Jul;57(1):113-119. (ATN 113) PMID 26095412 PMCID 4477274
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477274/

5 U01 HD 40533 and 5 U01 HD 40474
Lee S, Yamazaki M, Harris DR, Harper G, Ellen J, and the Adolescent Medicine Trials Network. Social Support and Human Immunodeficiency Virus-Status Disclosure to Friends and Family: Implications for Human Immunodeficiency Virus-Positive Youth. J Adolesc Health, 2015 Jul;57(1):73-80. (ATN 016b) PMID 25940217 PMCID 4478132
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478132/

5 U01 HD 40533 and 5 U01 HD 40474
Alcantara L, Harper GW, Keys CB, and the Adolescent Medicine Trials Network. “There’s Gotta be Some Give and Take”: Community Partner Perspectives on Benefits and Contributions associated with Community Partnerships for Youth. Youth Soc, 2015 Jul:47(1):462-485. (ATN 016b) PMID 26257446 PMCID 4529130
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529130/

5 U01 HD 40533 and 5 U01 HD 40474
Ellen JM, Greenberg N, Willard N, Stines S, Korelitz J, Boyer CB and the Adolescent Trials Network for HIV/AIDS Interventions. Cross-sectional survey comparing HIV risk behaviours of adolescent and young adult men who have sex with men only and men who have sex with men and women in the US and Puerto Rico. Sex Transm Infect, 2015 Sep;91(6):458-61.  (ATN 040b) PMID 25587181 PMCID 4500752

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500752/

5 U01 HD 40533 and 5 U01 HD 40474
Willard N, Chutuape K, Campbell-Stewart R, Boyer CB, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. Targeting Structural Change for HIV Prevention: A Process and Tool for Community Application. Health Promot Pract, 2015 Nov;16(6):837-48. (ATN 095/105) PMID 25776019 PMCID 4573386

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573386/

5 U01 HD 40533 and 5 U01 HD 40474
Chutuape K, Willard N, Cooper-Walker B, Boyer CB, Ellen J and the Adolescent Trials Network for HIV/AIDS Interventions. A Tailored Approach to Launch Community Coalitions focused on Achieving Structural Changes: Lessons Learned from HIV Prevention Mobilization Study. J Public Health Manag Pract, 2015 Dec;21(6):546-555. (ATN 095) PMID 26785397 PMCID 4721266

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721266/

 

2014

5 U01 HD 40533 and 5 U01 HD 40474
Philbin MM, Tanner AE, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Medicine Trials Network. Linking HIV-positive adolescents to care in 15 different clinics across the United States: Creating solutions to address structural barriers for linkage to care. AIDS Care, 2014 Jan;26(1):12-9.  (ATN 093)  PMID 23777542  PMCID 3872213
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872213/

5 U01 HD 40533 and 5 U01 HD 40474
Outlaw AY, Naar-King S, Tanney M, Belzer M, Aagenes A, Parsons JT, Greene LM, and the Adolescent Medicine Trials Network. The Initial Feasibility of a Computer-Based Motivational Intervention for Adherence for Youth Newly Recommended to Start Antiretroviral Treatment. AIDS Care, 2014 Jan;26(1):130-5. (ATN 072) PMID 23869650 PMCID 3872202
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872202/

5 U01 HD 40533 and 5 U01 HD 40474
Tanner AE, Philbin MM, DuVal A, Ellen J, Kapogiannis BG, Fortenberry JD, and the Adolescent Medicine Trials Network. ‘Youth friendly’ clinics: Considerations for linking and engaging HIV-infected adolescents into care. AIDS Care, 2014 Feb;26(2):199-205. (ATN 093) PMID 23782040  PMCID 4106414
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106414

5 U01 HD 40533 and 5 U01 HD 40474
Esposito-Smythers C, Brown LK, Wolff J, Xu J, and Thornton S for the Adolescent Medicine Trials Network. Substance Abuse Treatment for HIV Infected Young People: An Open Pilot Trial. J Subst Abuse Treat, 2014 Feb;46(2):244-50. (ATN 069) PMID 23988190 PMCID 3840092
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840092/

5 U01 HD 40533 and 5 U01 HD 40474
Nichols SL, Lowe A, Zhang X, Garvie PA, Patton D, Thornton S, Goldberger BA, Hou W, Goodnow MM, Sleasman JW, and the Adolescent Medicine Trials Network. Concordance Between Self-Reported Substance Use and Toxicology Among HIV-Infected and Uninfected At Risk Youth. Drug Alcohol Depend, 2014 Jan 1;134:376-82. (ATN 071/101)  PMID 24309297 PMCID 4006963
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006963/

5 U01 HD 40533 and 5 U01 HD 40474
Reed SJ, Miller RL, Francisco VT, and the Adolescent Medicine Trials Network. The Influence of Community Context on How Coalitions Achieve HIV-Preventive Structural Change. Health Educ Behav, 2014 Feb;41(1):100-7. (ATN 079) PMID 23855017  PMCID 3947250
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947250/

5 U01 HD 40533 and 5 U01 HD 40474
Whiteley LB, Brown LK, Swenson R, Kapogiannis BG, Harper GW, and the Adolescent Medicine Trials Network. Mental Health Care among HIV Infected Youth in Medical Care: Disparities and Equalities. J Int Assoc Provid AIDS Care, 2014 Jan-Feb;13(1):29-34. (ATN 086) PMID 23695228 PMCID 3883958
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883958/

5 U01 HD 40533 and 5 U01 HD 40474
Brothers J, Harper GW, Fernandez MI, Hosek SG, and the Adolescent Medicine Trials Network. EVOLUTION-Taking Charge and Growing Stronger: The Design, Acceptability and Feasibility of a Secondary Prevention Empowerment Intervention for Young Women Living with HIV. AIDS Patient Care STDs, 2014 Jan;28(1):33-42. (ATN 089)  PMID 24575438  PMCID 3894678
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894678/

5 U01 HD 40533 and 5 U01 HD 40474
Belzer ME, Naar-King S, Olson J, Sarr M, Thornton S, Kahana SY, Gaur A, Clark L, and the Adolescent Medicine Trials Network. The Use of Cell Phone Support for Non-Adherent HIV-Infected Youth and Young Adults: An Initial Randomized and Controlled Intervention Trial. AIDS Behav, 2014 Apr;18(4):686-96. (ATN 078) PMID 24271347 PMCID 3962719
http://www.ncbi.nlm.nih.gov/pubmed/24271347

5 U01 HD 40533 and 5 U01 HD 40474
Kennard B, Brown L, Hawkins L, Risi A, Radcliffe J, Emslie G, Mayes T, King T, Foxwell A, Buyukdura J, Bethel J, Naar-King S, Xu J, Lee S, Garvie P, London C, Tanney M, Thornton S, and the Adolescent Medicine Trials Network. Development and Implementation of Health and Wellness CBT for Individuals with Depression and HIV. Cogn Behav Pract, 2014 May;21(2),237-246. (ATN 080) PMID 24795524 PMCID 4002170
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002170/

5 U01 HD 40533 and 5 U01 HD 40474
Reed SJ, Miller RL, and the Adolescent Medicine Trials Network. The Benefits of Youth Engagement in HIV-Preventive Structural Change Interventions.  Youth Soc, 2014 Jul;46(4):528-545. (ATN 079) PMID 25328252  PMCID 4197976
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197976/

5 U01 HD 40533 and 5 U01 HD 40474
Rubinstein ML, Harris DR, Rudy BJ, Kapogiannis BG, Aldrovandi GM, Mulligan K, the ATN 021 protocol team, and the Adolescent Medicine Trials Network. Exploration of the Effect of Tobacco Smoking on Metabolic Measures in Young People Living with HIV. AIDS Res Treat, 2014; 2014: 740545. (ATN 021a/021b) PMID 25114801 PMCID 4119894
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119894/

5 U01 HD 40533 and 5 U01 HD 40474
Ellen JM, Kapogiannis B, Fortenberry JD, Xu J, Willard N, DuVal A, Pace J, Loeb J, Monte D, Bethel J, and the Adolescent Medicine Trials Network. HIV Viral Load Levels and CD4+ Cell Counts of Youth in Fourteen U.S. Cities. AIDS, 2014 May 15;28(8):1213-9. (ATN 093)
PMID 25028912 PMCID 4151121
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151121/

5 U01 HD 40533 and 5 U01 HD 40474
Lally M, Goldsworthy R, Sarr M, Kahn JA, Brown LK, Peralta L, Zimet GD, and the Adolescent Medicine Trials Network. Evaluation of an Intervention among Adolescents to Reduce Preventive Misconception in HIV Vaccine Clinical Trials. J Adolesc Health, 2014 Aug;55(2):254-9. (ATN 076) PMID 24613097 PMCID 4108563
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108563/

5 U01 HD 40533 and 5 U01 HD 40474
Philbin MM, Tanner AE, DuVal A, Ellen J, Xu J, Kapogiannis B, Bethel J, Fortenberry JD, and the Adolescent Medicine Trials Network. Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen Adolescent Medicine Clinics in the United States. AIDS Behav, 2014 Aug;18(8):1501-10. (ATN 093) PMID 24682848 PMCID 4000283
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000283/

5 U01 HD 40533 and 5 U01 HD 40474 
Harper GW, Lemos D, Hosek S, and the Adolescent Medicine Trials Network. Stigma Reduction in Adolescents and Young Adults Newly Diagnosed with HIV in the U.S.: Findings from the Project ACCEPT Intervention. AIDS Patient Care STDs, 2014 Oct;28(10):543-54. (ATN 068) PMID 25216106 PMCID 4183905
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183905/

5 U01 HD 40533 and 5 U01 HD 40474
Savel C, Mierzwa S, Gorbach P, Lally M, Zimet G, Meyer K, Souidi S, and the Adolescent Trials Network for HIV/AIDS Interventions. Web-based, mobile-device friendly, self-report survey system incorporating avatars and gaming console techniques. Online J Public Health Inform, 2014 6(2):e191. (ATN 123) PMID 25422726 PMCID 4235324
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235324/

5 U01 HD 40533 and 5 U01 HD 40474
Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K, and the Adolescent Medicine Trials Network. Vitamin D3 Supplementation Increases Fibroblast Growth  Factor-23 in HIV-Infected Youth treated with Tenofovir Disoproxil Fumarate. Antivir Ther, 2014 19(6):613-618. (ATN 063) PMID 24535626 PMCID 4135028
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135028/

5 U01 HD 40533 and 5 U01 HD 40474
Boyer C, Robles-Schrader G, Li SX, Miller R, Korelitz J, Price GN, Rivera Torres C, Chutuape K, Stines S, Straub D, Peralta L, Febo I, Hightow-Weidman L,  Gonin R, Kapogiannis B, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. A Comparison of Network-based Strategies for Screening At-Risk Hispanic/Latino Adolescents and Young Adults for Undiagnosed Asymptomatic HIV Infection. J Adolesc Health, 2014 Dec;55(6):765-73. (ATN 096) PMID 25223476 PMCID 4252839
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252839/

5 U01 HD 40533 and 5 U01 HD 40474
Chutuape KS, Muyeed AZ, Willard N, Greenberg L, Ellen JM, and the Adolescent Medicine Trials Network. Adding to the HIV Prevention "Mix" - the Achievement of Structural Change Objectives by 13 Connect to Protect® Coalitions. Glob J Community Psychol Pract, 2014 Dec; 5(2):1-8. (ATN 040) PMID 25632407 PMCID 4306189
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306189/

5 U01 HD 40533 and 5 U01 HD 40474
Harper GW, Bruce D, Hosek SG, Fernandez MI, Rood B, and the Adolescent Medicine Trials Network. Resilience Processes Demonstrated by Young Gay and Bisexual Men Living with HIV: Implications for Intervention. AIDS Patient Care STDs, 2014 Dec;28(12):666-76. (ATN 070) PMID 25329778 PMCID 4250951
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250951/

 

2013

5 U01 HD 40533 and 5 U01 HD 40474
Harper GW, Fernandez MI, Bruce D, Hosek SG, Jacobs RJ, and the ATN. The Role of Multiple Identities in Adherence to Medical Appointments among Gay/Bisexual Male Adolescents Living with HIV. AIDS Behav, 2013 Jan;17(1):213-223. (ATN 070) PMID 22041930 PMCID 3367130
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367130/

5 U01 HD 40533 and 5 U01 HD 40474
MacDonell K, Naar-King S, Huszti H, Belzer M, and the Adolescent Medicine Trials Network. Barriers to Medication Adherence in Behaviorally and Perinatally Infected Youth Living With HIV. AIDS Behav, 2013 Jan;17(1):86-93. (ATN 086) PMID 23142855 PMCID 3549030
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549030/

5 U01 HD 40533 and 5 U01 HD 40474
Miller RL, Reed SJ, Francisco V, and the Adolescent Medicine Trials Network. Accomplishing structural change: Identifying intermediate indicators of success. Am J Community Psychol, 2013 Mar;51(1-2):232-42. (ATN 079) PMID 22875684  PMCID 3495085
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495085/

5 U01 HD 40533 and 5 U01 HD 40474
Boyer CB, Hightow-Weidman L, Bethel J, Li SX, Henry-Reid L, Futterman D, Maturo D, Straub DM, Kapogiannis BG, Howell K, Reid S, Lowe J, and Ellen JM. An Assessment of the Feasibility and Acceptability of a Friendship-Based Social Network Recruitment Strategy to Screen At-Risk African American and Hispanic/Latina Young Women for HIV Infection. JAMA Pediatr, 2013 Mar 1;167(3):289-96. (ATN 067) PMID 23338776 PMCID 3596427
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596427/

5 U01 HD 40533 and 5 U01 HD 40474
Syed SS, Balluz RS, Kabagambe EK, Meyer WA, Lukas S, Wilson CM, Kapogiannis BG, Nachman SA, Sleasman JW, and the Adolescent Medicine Trials Network. Assessment of biomarkers of cardiovascular risk among HIV Type-1 infected adolescents: role of soluble Vascular Cell Adhesion Molecule (sVCAM) as an early indicator of endothelial inflammation. AIDS Res Hum Retroviruses, 2013 Mar;29(3):493-500. (ATN 083) PMID 23062187  PMCID 3581064
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581064/

5 U01 HD 40533 and 5 U01 HD 40474
Bruce D, Harper GW, Fernandez MI, and the Adolescent Medicine Trials Network. Heavy Marijuana Use among Gay and Bisexual Male Emerging Adults Living with HIV/AIDS: A Mixed Methods Study. J HIV/AIDS Soc Serv, 12:26–48, 2013. (ATN 070) PMID 23805056  PMCID 3691072
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691072/

5 U01 HD 40533 and 5 U01 HD 40474
Bruce D, Harper GW, Suleta K, and the Adolescent Medicine Trials Network. Sexual Risk Behavior and Risk Reduction Beliefs among HIV-positive Young Men who have Sex with Men. AIDS Behav, 2013 May;17(4):1515-23. (ATN 070) PMID 22350830 PMCID 3361604
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361604/

103. 5 U01 HD 40533 and 5 U01 HD 40474
Bruce D, Kahana S, Harper GW, Fernandez MI, and the Adolescent Medicine Trials Network. Alcohol Use Predicts Sexual Risk Behavior With HIV-Negative or Partners of Unknown Status Among Young HIV-Positive Men Who Have Sex With Men. AIDS Care, 2013 May;25(5):559-65. (ATN 070) PMID 22971018 PMCID 3522779
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522779/

5 U01 HD 40533 and 5 U01 HD 40474
Clum GA, Czaplicki L, Andrinopoulos K, Muessig K, Hamvas L, Ellen JM, and the Adolescent Medicine Trials Network. Strategies and Outcomes of HIV Status Disclosure in HIV Positive Young Women with Abuse Histories. AIDS Patient Care STDs, 2013 Mar;27(3):191-200. (ATN 053) PMID 23596649
PMCID 3595953
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595953/

5 U01 HD 40533 and 5 U01 HD 40474 
Lee S, Kapogiannis BG, Flynn PM, Rudy BJ, Bethel J, Ahmad  S, Tucker D, Abdalian SE, Hoffman D, Wilson CM, Cunningham CK and the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN). Comprehension of a simplified assent form in a vaccine trial for adolescents. J Med Ethics, 2013 Jun;39(6):410-2. (ATN 025) PMID 23349510 PMCID 3655100
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655100/

5 U01 HD 40533 and 5 U01 HD 40474
Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, Fernandez MI, Rutledge B, Martinez J, Garofalo R, Wilson CM, and the Adolescent Medicine Trials Network. Project PrEPare (ATN 082): The Acceptability and Feasibility of an HIV Pre-Exposure Prophylaxis (PrEP) Trial with Young Men who Have Sex With Men (YMSM). J Acquir Immune Defic Syndr, 1 April 2013;62(4):447–456. (ATN 082) PMID 24135734 PMCID 3656981
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656981/

5 U01 HD 40533 and 5 U01 HD 40474
Reed SJ, Miller RL, and the Adolescent Medicine Trials Network. Connect to Protect® and the Creation of AIDS-Competent Communities. AIDS Educ and Prev, 2013;25(3): 255–267. (ATN 079) PMID 23762979  PMCID 3764995
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764995/

5 U01 HD 40533 and 5 U01 HD 40474
Naar-King S, Outlaw AY, Saar M, Parsons JT, Belzer M, MacDonell K, Tanney M, Ondersma SJ, and the Adolescent Medicine Trials Network. Motivational Enhancement System for Adherence (MESA): Pilot Randomized Trial of a Brief Computer-Delivered Prevention Intervention for Youth Initiating Antiretroviral Treatment. J Pediatr Psychol, 2013 Jul;38(6):638-48. (ATN 072) PMID 23359664 PMCID 3701125
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701125/

5 U01 HD 40533 and 5 U01 HD 40474
Kahn J, Xu J, Kapogiannis B, Rudy B, Gonin R, Liu N, Wilson CM, Worrell C, Squires K, and the Adolescent Medicine Trials Network. Immunogenicity and Safety of the Human Papillomavirus 6, 11, 16, 18 Vaccine in HIV-Infected Young Women. Clin Infect Dis, 2013 Sep;57(5):735-44. (ATN 064) PMID 23667266 PMCID 3739463
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739463/

5 U01 HD 40533 and 5 U01 HD 40474
Giguere R, Zimet GD, Kahn JA, Dolezal C, Leu CS, Mabragana M, Carballo-Dieguez A, McGowan I, and the Adolescent Medicine Trials Network. The Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico. World J AIDS, 2013 Sep;3(3). (ATN 062) PMID 24324918  PMCID 3855411
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855411/

5 U01 HD 40533 and 5 U01 HD 40474
Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon C, Mulligan K and the Adolescent Medicine Trials Network. Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: Cause of a functional vitamin D deficiency?  Antimicrob Agents Chemother, 2013 Nov;57(11):5619-28. (ATN 063)  PMID 24002093 PMCID 3811269
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3811269/

5 U01 HD 40533 and 5 U01 HD 40474
Hosek SG, Green KR, Siberry G, Lally M, Kapogiannis B, and the Adolescent Medicine Trials Network. Integrating Behavioral HIV Interventions into Biomedical Prevention Trials with Youth: Lessons from Chicago’s Project PrEPare. J HIV AIDS Soc Serv, 12:333–348, 2013 (ATN 082) PMID 24223514
PMCID 3818104
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818104/

5 U01 HD 40533 and 5 U01 HD 40474
Ott MA, Alexander AB, Lally M, Steever JB, Zimet GD, and the Adolescent Medicine Trials Network. Preventive Misconception and Adolescents’ Knowledge about HIV Vaccine Trials. J Med Ethics, 2013 Dec;39(12):765-71. (ATN 076)  PMID 23355050 PMCID 3677956
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677956/

5 U01 HD 40533 and 5 U01 HD 40474
Mabragana M, Carballo-Dieguez A, Giguere R on behalf of the ATN 062 and MTN 004 Protocol Teams, and the Adolescent Medicine Trials Network. Young women’s experience with using Videoconferencing for the assessment of sexual behavior and microbicide use. Telemed J E Health, 2013 Nov;19(11):866-71. (ATN 062)  PMID 24050616 PMCID 3810614
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810614/

5 U01 HD 40533 and 5 U01 HD 40474
Bangi AK, Dolcini MM, Harper GW, Boyer CB, Pollack LM and the Adolescent Medicine Trials Network. Psychosocial Outcomes of Sexual Risk Reduction in a Brief Intervention for Urban African American Female Adolescents. J HIV AIDS Soc Serv, 2013;12(2):146-159.  (ATN 034)  PMID 24039550 PMCID 3768285
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3768285/

5 U01 HD 40533 and 5 U01 HD 40474
Tanner AE, Philbin MM, Ott MA, DuVal A, Ellen J, Kapogiannis B, Fortenberry JD, and the Adolescent Medicine Trials Network. Linking HIV Positive adolescents into care: The effects of relationships between local health departments and adolescent medicine clinics. J HIV AIDS Soc Serv, 2013;12(3-4):424-436. (ATN 093)  PMID 24273461 PMCID 3835468
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835468/

5 U01 HD 40533 and 5 U01 HD 40474
Porter TR, Li X, Stephensen CB, Mulligan K, Rutledge B, Flynn PM, Lujan-Zilbermann J, Hazra R, Wilson CM, Havens PL, Tang J, and the Adolescent Medicine Trials Network. Genetic Associations with 25-Hydroxyvitamin D Deficiency in HIV-1-Infected Youth: Fine-Mapping for the GC/DBP Gene That Encodes the Vitamin D-Binding Protein. Front Genet; 4:234. (ATN 063) PMID 24294218  PMCID 3827582
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827582/

5 U01 HD 40533 and 5 U01 HD 40474
Nichols SL, Bethel J, Garvie P, Woods SP, Patton D, Thornton S, Kapogiannis BG, Ren W, Li T, Major-Wilson H, Puga A, and the Adolescent Medicine Trials Network. Neurocognitive Functioning in Antiretroviral Therapy-Naïve Youth with Behaviorally Acquired Human Immunodeficiency. J Adolesc Health, 2013 Dec;53(6):763-71. (ATN 071) PMID 23972941 PMCID 3878875
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878875/

 

2012

5 U01 HD 40533 and 5 U01 HD 40474 
Dempsey AG, Garner R, Naar-King S, Lau CY.  Patterns of Disclosure among HIV Positive Youth Who Are HIV Positive: A Multisite Study.  J Adolesc Health, 2012 Mar;50(3):315-7. (ATN 004) PMID 22325140 PMCID 3278707

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278707/

5 U01 HD 40533 and 5 U01 HD 40474 
Hosek S, Brothers J, Lemos D and the ATN. What HIV-Positive Young Women Want from Behavioral Interventions: A Qualitative Approach. AIDS Patient Care STDs, 2012 May;26(5):291-7. (ATN 073) PMID 22675725  PMCID 3335104

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335104/

5 U01 HD 40533 and 5 U01 HD 40474
Torres RS, Harper GW, Sanchez B, Fernandez MI. Examining Natural Mentoring Relationships among Self-Identified Gay, Bisexual, and Questioning (GBQ) Male Youth. Child Youth Serv Rev, 2012 Jan; 34(1):8-14. (ATN 020) PMID 23408225  PMCID 3568771
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568771/

5 U01 HD 40533 and 5 U01 HD 40474 
Murphy DA, Chen X, Naar-King S, Parsons JT, and the ATN. Alcohol and Marijuana Use Outcomes in the Healthy Choices Motivational Interviewing Intervention for HIV-positive Youth. AIDS Patient Care STDs 2012 Feb;26(2):95-100 (ATN 004)  PMID 22191456 PMCID 3266518

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266518/

4 R01 DA 014706 and 5 U01 HD 40533
Martinez J, Harper G, Carlton RA, Hosek S, Bojan K, Clum G, Ellen J, and the Adolescent Medicine Trials Network. The Impact of Stigma on Medication Adherence among HIV-Positive Adolescent and young adult females  and the Moderating Effects of Coping and Satisfaction with Health Care.  AIDS Patient Care STDs 2012 Feb;26(2):108-15. (ATN 009) PMID 22149767 PMCID 3266519
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266519/

K01 MH 070278, 4 R01 DA 0147065, and U01 HD 40533  
Finger JL, Clum GA, Trent ME, and Ellen JM. Desire for Pregnancy and Risk Behavior in Young HIV Positive Women. AIDS Patient Care and STDs 2012 Mar;26(3):173-180. (ATN 009) PMID 22482121 PMCID 3286807

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286807/

5 U01 HD 40533 and 5 U01 HD 40474
Bruce D, Harper G, Fernandez MI, Jamil OB, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions.  Age-Concordant and Age-Discordant Sexual Behavior among Gay and Bisexual Male Adolescents. Arch Sex Behav, 2012 Apr;41(2):441-8.  (ATN 020) PMID 21290255 PMCID 3150640
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150640/

5 U01 HD 40533 and 5 U01 HD 40474
Havens PL, Stephenson CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilberman J, Baker A, Kapogiannis BG, Mulligan K and the Adolescent Medicine Trials Network. Vitamin D3 Decreases Parathyroid Hormone in HIV-infected Youth Being Treated with Tenofovir: a Randomized, Placebo-Controlled Trial. Clin Infect Dis, 2012 Apr;54:1013-1025. (ATN 063)  PMID 22267714 PMCID 3297650
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297650/

5 U01 HD 40533 and 5 U01 HD 40474
Kahn JA, Xu J, Zimet GD, Liu N, Gonin R, Dillard ME, Squires K, and the Adolescent Medicine Trials Network. Risk Perceptions after Human Papillomavirus Vaccination in HIV-Infected Adolescents and Young Adult Women. J of Adolesc Health, 2012 May;50(5):464-70. (ATN 064) PMID 22525109 PMCID 3336095
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3336095/

5 U01 HD 40533 and 5 U01 HD 40474 
Harper GW, Brodsky A, Bruce D. What's Good about Being Gay?: Perspectives from Youth. J LGBT Youth, 2012 Winter;9(1):22-41.  (ATN 020) PMID 22514751 PMCID 3326393
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326393/

5 U01 HD 40533 and 5 U01 HD 40474
Agwu AL, Bethel J, Hightow-Weidman LB, Sleasman JW, Wilson CM, Rudy B, Kapogiannis BG, and the Adolescent Medicine Trials Network. Substantial Multiclass Transmitted Drug Resistance and Drug-Relevant Polymorphisms among Treatment-Naïve Behaviorally HIV-Infected Youth. AIDS Patient Care STDs 2012 28(4):193-196. (ATN 061) PMID 22563607 PMCID 3317397
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317397/

5 U01 HD 40533 and 5 U01 HD 40474
Martinez J, Lemos D, Hosek S, and the Adolescent Medicine Trials Network. Stressors and Sources of Support: The Perceptions and Experiences of Newly Diagnosed Latino Youth Living with HIV. AIDS Patient Care STDs 2012 26(5):281-290. (ATN 055) PMID 22536931 PMCID 3335135
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335135/

5 U01 HD 40533 and 5 U01 HD 40474
Harper, GW, Willard, N., Ellen, JM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Connect to Protect®: Utilizing community mobilization and structural change to prevent HIV infection among youth. J Prev Interv Community 40:2, 81-86. (ATN 040) PMID 24188350  PMCID 3819046
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819046/

5 U01 HD 40533 and 5 U01 HD 40474
Doll M., Harper GW, Robles-Schrader GM, Johnson  J., Bangi, AK., Velagaleti, S, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Perspectives of community partners and researchers about factors impacting coalition functioning over time. J Prev Interv Community 40:2, 87-102. (ATN 040) PMID 24188351  PMCID 3818728
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818728/

5 U01 HD 40533 and 5 U01 HD 40474 
Willard N, Chutuape K, Stines S, and Ellen JM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Bridging the Gap Between Individual Level Risk for HIV and Structural Determinants: Using Root Cause Analysis in Strategic Planning. J Prev Interv Community 40:2, 103-117. (ATN 040) PMID 24188352  PMCID  3818729
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818729/

5 U01 HD 40533 and 5 U01 HD 40474
Reed SJ, Miller RL, Francisco VT, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Programmatic capacity and HIV structural change interventions: Influences on coalitions' success and efficiency in accomplishing intermediate outcomes. J Prev Interv Community 40:2, 118-130. (ATN 079) PMID 24188353  PMCID  3818714
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818714/

5 U01 HD 40533 and 5 U01 HD 40474
Robles-Schrader GM, Harper GW, Purnell M, and Monarrez V, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Differential Challenges in Coalition Building among HIV Prevention Coalitions Targeting Specific Youth Populations. J Prev Interv Community 40:2, 131-148. (ATN 040) PMID 24188354  PMCID 3818727
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818727/

5 U01 HD 40533 and 5 U01 HD 40474 
Lin AJ, Dudek JC, Francisco VT, Castillo M, Freeman P, Martinez M, Sniecinski K, Young K, Ellen JM and the ATN. Challenges and approaches to mobilizing communities for HIV prevention among young men who have sex with men of color. J Prev Interv Community 40:2, 149-164. (ATN 040) PMID 24188355  PMCID 3818719
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818719/

5 U01 HD 40533 and 5 U01 HD 40474
Castillo M, Palmer BJ, Rudy BJ, Fernandez MI, and the ATN. Creating partnerships for HIV prevention among YMSM: the Connect to Protect Project and House and Ball Community in Philadelphia. J Prev Interv Community 40:2, 165-175. (ATN 040)  PMID 24188356 PMCID 3823243
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823243/

4 R01 DA 014706
Clum GA, Chung SE, Ellen JM, Perez LV, Murphy D, and Harper GW. Victimization and Sexual Risk Behavior in Young, HIV Positive Women: Exploration of Mediators. AIDS Behav, 2012 May;16(4):999-1010. (ATN 009) PMID 21452050 PMCID 3338894
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338894/

5 U01 HD 40533 and 5 U01 HD 40474 
Miller RL, Reed SJ, and the ATN 079 Protocol Team for the Adolescent Trials Network for HIV/AIDS Interventions. Conflict Transformation, Stigma, and HIV-Preventive Structural Change. Am J Commun Psychol, 2012 Jun;49(3-4):378-392. (ATN 079) PMID 21805217 PMCID 3348352
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348352/

5 U01 HD 40533 and 5 U01 HD 40474
Wilson EC, Iverson E, Belzer M, Garofalo R, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Parental support and condom use among transgender female youth. J Assoc Nurses AIDS Care, 2012 Jul;23(4):306-17. (ATN 039) PMID 22079675 PMCID 3288276
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288276/

5 U01 HD 40533 and 5 U01 HD 40474
Mulligan K, Harris DR, Emmanuel P, Fielding RA, Worrell C, Kapogiannis BG, Monte D, Sleasman J, Wilson CM, Aldrovandi GM and the Adolescent Medicine Trials Network. Low Bone Mass in Behaviorally HIV-Infected Young Men on Antiretroviral Therapy: Adolescent Trials Network (ATN) Study 021B. Clin Infec Dis 2012 Aug;55(3):461-468. (ATN 021b) PMID 22573848 PMCID 3491777
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491777/

5 U01 HD 40533 and 5 U01 HD 40474 
Tanney MR, Naar-King S, MacDonnel K, and the ATN. Depression and Stigma in High Risk Youth Living with HIV: A Multisite Study. J Pediatr Health Care, 2012 Jul;26(4):300-5. (ATN 004) PMID 22726715  PMCID 3383773
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383773/

5 U01 HD 40533 and 5 U01 HD 40474 
Bruce D, Harper GW. Future Life Goals of HIV-Positive Gay and Bisexual Male Emerging Adults. J Adolesc Res, 2012 Jul;27(4):449-470. (ATN 070) PMID 22844182  PMCID 3405144
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405144/

5 U01 HD 40533 and 5 U01 HD 40474
Brennan J, Kuhns LM, Johnson AK, Belzer M, Wilson EC, Garofalo R, and the Adolescent Medicine Trials Network. Syndemic Theory and HIV-related Risk among Young Transgender Women: The Role of Multiple, Co-Occurring Health Problems and Social Marginalization. Am J Public Health, 2012 Sep;102(9):1751-1757. (ATN 039) PMID 22873480  PMCID 3416048
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416048/

5 U01 HD 40533 and 5 U01 HD 40474
Carballo-Dieguez A, Giguere R, Dolezal C, Chen B, Kahn J, Zimet G, Mabragana M, Leu CS, McGowan I, and the Adolescent Medicine Trials Network. “Tell Juliana”:  Acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a Phase 1 microbicide study. AIDS Behav, 2012 Oct;16(7):1761-74. (ATN 062) PMID 21863338 PMCID 3272128
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272128/

5 U01 HD 40533 and 5 U01 HD 40474
Fortenberry JD, Martinez J, Rudy BJ, Monte D, and the Adolescent Medicine Trials Network. Linkage to care for HIV-positive Adolescents: A multi-site study of the Adolescent Medicine Trials Units of the Adolescent Trials Network. J Adolesc Health, 2012 Dec;51(6):551-6. (ATN 066a) PMID 23174464 PMCID 3505853
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505853/

5 U01 HD 40533 and 5 U01 HD 40474
Aaron KJ, Kempf MC, Christenson RH, Wilson CM, Muntner P, Shrestha S, and the Adolescent Medicine Trials Network. Prevalence of Proteinuria and Elevated Serum Cystatin C among HIV-infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) Study. J Acquir Immune Defic Syndr, 2012 Dec 1;61(4):499-506. (ATN 100) PMID 22918154  PMCID 3494783
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494783/

5 U01 HD 40533 and 5 U01 HD 40474
Havens PL, Mulligan K, Hazra R, Flynn P, Rutledge B, Van Loan MD, Lujan-Zilbermann J, Kapogiannis BG, Wilson CM, Stephensen CB, the ATN 063 study team, and the Adolescent Medicine Trials Network. Serum 25-hydroxyvitamin D3 Response to Vitamin D3 Supplementation 50,000 IU Monthly in Youth with HIV-1 Infection. J Clin Endocrinol Metab, 2012 Nov;97(11):4004-4013. (ATN 063) PMID 22933542 PMCID 3485594
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485594/

5 U01 HD 40533 and 5 U01 HD 40474
Kahn JA, Burk RD, Squires KE, Kapogiannis BG, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson CM, and the Adolescent Medicine Trials Network. Prevalence and Risk Factors for HPV in HIV-Positive Young Women Receiving Their First HPV Vaccination. J Acquir Immune Defic Syndr, 2012 Nov 1;61(3):390-399. (ATN 064) PMID 22820809 PMCID 3480995
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480995/

 

2011

5 U01 HD 40533 and 5 U01 HD 40474 
MacDonell KE, Naar-King S, Murphy DA, Parsons JT, Huszti H. Situational Temptation for HIV Medication Adherence in High Risk Youth. AIDS Patient Care STDs, 2011 Jan;25(1):47-52. (ATN 004) PMID 21162691 PMCID 3030911

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3030911/

5 U01 HD 40533 and 5 U01 HD 40474
Gilliam PP, Ellen JM, Leonard L, Kinsman S,  Jevitt CM, Straub DM and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Transition of Adolescents with HIV to Adult Care: Characteristics and Current Practices of the Adolescent Trials Network for HIV/AIDS Interventions. J Assoc Nurses AIDS Care, 2011 July;22(4):283-294.  (ATN 060) PMID 20541443 PMCID 3315706
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315706/

5 U01 HD 40533 and 5 U01 HD 40474 
Hosek SG, Lemos D, Harper GW, and Telander K. Evaluating the Acceptability and Feasibility of Project ACCEPT: An Intervention for Youth Newly Diagnosed with HIV.  AIDS Educ Prev, 2011 Apr;23(2):128-44.  (ATN 068) PMID 21517662 PMCID 3280923
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280923/

5 U01 HD 40533 and 5 U01 HD 40474 
Flynn PM, Cunningham CK, Rudy B, Wilson CM, Kapogiannis B, Worrell C, Bethel J, Monte D, Bojan K, and the ATN. Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens. J Acquir Immune Defic Syndr, 2011 Apr;56(4):325-32.  (ATN 024) PMID 21350366 PMCID 3079288

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079288/

5 U01 HD 40533 and 5 U01 HD 40474
Bruce D, Harper GW, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Operating Without a Safety Net: Gay Male Adolescents and Emerging Adults’ Experiences of Marginalization and Migration, and Implications for Theory of Syndemic Production of Health Disparities.  Health Educ Behav, 2011 Aug;38(4):367-378. (ATN 070) PMID 21398621 PMCID 3149744

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149744/

5 U01 HD 40533 and 5 U01 HD 40474 
Chen X, Murphy DA, Naar-King S, Parsons JT, and the ATN. A Clinic-Based Motivational Intervention Improves Condom Use Among Subgroups of Youth Living with HIV. J Adolesc Health, 2011 Aug;49(2):193-8. (ATN 004) PMID 21783053 PMCID 3282587

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282587/

5 U01 HD 40533 and 5 U01 HD 40474 
Straub DM, Arrington-Sanders R, Harris DR, Willard N, Kapogiannis B, Emmanuel P, Futterman D, Ellen JM, and the ATN. Correlates of HIV Testing History among Urban Youth Recruited through Venue-Based Testing in 15 US Cities. Sex Transm Dis, 2011 Aug;38(8):691-696. (ATN 016b) PMID: 21758020 PMCID 3155007

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155007/

5 U01 HD 40533 and 5 U01 HD 40474 
Freeman P, Walker BC, Harris DR, Garofalo R, Willard N, Ellen JM, and the ATN. Methamphetamine Use and Risk for HIV Among Young Men who have Sex with Men in 8 U.S. Cities. Arch Pediatr Adolesc Med. 2011 Aug;165(8):736-740. (ATN 016b) PMID 21810635 PMCID 3278965

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278965/

5 U01 HD 40533 and 5 U01 HD 40474
Baheti G, Kiser JJ, Havens PL, Fletcher CV, and the Adolescent Medicine Trials Network. Plasma and Intracellular Population Pharmacokinetic Analysis of Tenofovir in HIV-1 Infected Patients.  Antimicrobial Agents and Chemotherapy, 2011 Nov; 55(11):5294-5299. (ATN 056) PMID: 21896913 PMCID 3194996
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194996/

4 R01 DA 014706
Andrinopoulos K, Clum G, Murphy DA, Harper G, Perez L. Xu J, Cunningham S, Ellen JM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Health Related Quality of Life and Psychosocial Correlates among HIV-infected Adolescent and Young Adult Women in the US. AIDS Educ Prev, 2011 Aug;23(4):367-81. (ATN 009) PMID 21966746 PMCID 3287350

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287350/

5 U01 HD 40533 and 5 U01 HD 40474
Giguere R, Carballo-Dieguez A, Ventuneac A, Magbragana M, Dolezal C, Chen BA, Kahn JA, Zimet GD, McGowan I, and the Adolescent Medicine Trials Network. Variations in microbicide gel acceptability among young women in the USA and Puerto Rico. Culture, Health & Sexuality 2012 Feb;14(2):151-66. (ATN 062) PMID 22084840 PMCID 3265079

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265079/

5 U01 HD 40533 and 5 U01 HD 40474 
Fernandez MI, Hosek S, Warren JC, Jacobs RJ, Hernandez N, Martinez J, and the ATN. Development of an Easy to Use Tool to Assess HIV treatment readiness in Adolescent Clinical Settings. AIDS Care, 2011 Nov;23(11):1492-9. (ATN 065) PMID 22022853 PMCID 3203751

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203751/

 

2010

5 U01 HD 40533 and 5 U01 HD 40474
Sill AM, Constantine NT, Wilson CM, Peralta L. Demographic Profiles of Newly Acquire HIV Infections Among Adolescents and Young Adults in the U.S. J Adolesc Health, 2010;46: 93–96. (ATN 022) PMID 20123264 PMCID 2817989

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817989/

5 U01 HD 40533 and 5 U01 HD 40474
Mulligan K, Harris DR, Monte D, Stoszek S, Emmanuel P, Hardin DS, Kapogiannis BG, Worrell C, Meyer WA, Sleasman J, Wilson CM, Aldrovandi GM. Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network Study 021. Clin Infect Dis, 2010;50:106-114.  (ATN 021a) PMID 19947855 PMCID 2939739

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939739/

5 U01 HD 40533 and 5 U01 HD 40474
Murphy DA, Lam P, Naar-King S, Harris DR, Parsons JT, Muenz LR and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Health Literacy and Antiretroviral Adherence Among HIV-infected Adolescents. Patient Educ Couns, 2010; 79: 25-29. (ATN 004) PMID 19665860 PMCID 2839047
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839047/

5 U01 HD 40533 and 5 U01 HD 40474 
Ziff MA, Willard N, Harper GW, Bangi AK, Johnson J, Ellen JM and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Connect to Protect®   Researcher-Community Partnerships: Assessing Change in Successful Collaboration Factors over Time. Glob J of Community Psych Practice, 2010 Jan 14; 1(1): 31-39. (ATN 016b) PMID 21152354  PMCID 2998234
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998234/

5 U01 HD 40533 and 5 U01 HD 40474
Wilson BDM, Harper GW, Hidalgo MA, Jamil OB, Torres RS Fernandez MI, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Negotiating Dominant Masculinity Ideology: Strategies used by Gay, Bisexual and Questioning Male Adolescents. Am J of Community Psycho Practl, 2010; Jan;1(1):32-39. (ATN 020) PMID: 20082238 PMCID 2906685
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906685/

5 U01 HD 40533 and 5 U01 HD 40474
Tanney MR, Naar-King S, Murphy DA, Parsons JT, Janisse H, ATN 004 Protocol Team, Adolescent Trials Network for HIV/AIDS Interventions.  Multiple Risk Behaviors among Youth Living with Human Immunodeficiency Virus in Five US Cities.  J Adolesc Health, 2010 Jan;46(1):11-16. (ATN 004) PMID 20123252 PMCID 2818022

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818022/

5 U01 HD 40533 and 5 U01 HD 40474
Dolcini MM, Harper GW, Boyer CB, Pollack LM and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Project ORE: A Friendship-Based Intervention to Prevent HIV/STI in Urban African American Adolescent Females. Health Educ Beha, 2010 Feb;37(1):115-32 (ATN 034) PMID 19535612 PMCID 2922952
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922952/

4 R01 DA 014706
Dietz ERM, Clum G, Chung S, Leonard L, Murphy DA, Perez L, Harper G, Ellen JM. Adherence to scheduled appointments among HIV-infected female youth in five US cities. J Adolesc Health, 46 (2010) 278–283. (ATN 009) PMID 20159506  PMCID 2824596 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824596/

5 U01 HD 40533 and 5 U01 HD 40474
Chutuape KS, Willard N, Sanchez K, Straub DM, Ochoa TN, Howell K, Rivera C, Ramos I, Ellen JM and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Mobilizing Communities around HIV Prevention for Youth: How Three Coalitions Applied Key Strategies to Bring about Structural Changes. AIDS Educ Prev, 22(1), 15-27, 2010. (ATN 040)  PMID 20166784  PMCID 2850206
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850206/

5 U01 HD 40533 and 5 U01 HD 40474
Outlaw AY, Naar-King S, Janisse H, Parsons JT, and the Adolescent Trials Network for HIV/AIDS Interventions.  Predictors of Condom Use in a Multi-Site Study of High-Risk Youth Living with HIV. AIDS Educ Prev, 2010 Feb: 22(1), 1-14.  (ATN 004)  PMID 20166783  PMCID 2859092
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859092/

5 U01 HD 40533 and 5 U01 HD 40474
Rudy BJ, Murphy DA, Harris DR, Muenz L, Ellen JE and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Prevalence and Interactions of Patient-Related Risks for Non-Adherence to Antiretroviral Therapy among Perinatally-Infected Youth in the United States. AIDS Patient Care STDs, 2010; 24(2): 97-104.  (ATN 023b) PMID 20059354  PMCID 2859763
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859763/

5 U01 HD 40533 and 5 U01 HD 40474
Barnes W, D’Angelo L, Belzer M, Schroeder S, Palmer-Castor J, Futterman D, Kapogiannis B, Muenz L, Harris DR, Ellen JM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Identification of HIV Infected 12 to 24 Year Old Men and Women in 15 US Cities Through Venue-Based Testing. Arch Peds & Adol Med, 2010;164(3):273-276. (ATN 016b) PMID 20194262 PMCID 2903430

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903430/

5 U01 HD 40533 and 5 U01 HD 40474
Mehta N, Cunningham CK, Flynn P, Pepe J, Obaro S, Kapogiannis BG, Bethel J, Luzuriaga K, and the Adolescent Trials Network for HIV/AIDS Interventions. Impaired Generation of Hepatitis B Virus-specific Memory B Cells in HIV Infected Individuals Following Vaccination. Vaccine 2010 May 7;28(21):3672-8. (ATN 048) PMID 20356567 PMCID 2862082
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862082/

5 U01 HD 40533 and 5 U01 HD 40474
Naar-King S, Kolmodin K, Parsons JT, Murphy D, Wright K and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Psychosocial Factors and Substance Use in High Risk Youth Living with HIV: A Multisite Study. AIDS Care, 2010 Apr; 22(4):475-82. (ATN 004) PMID 20146112 PMCID 2858229
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858229/

5 U01 HD 40533 and 5 U01 HD 40474
Naar-King S, Parsons JT, Murphy DA, Kolmodin K, Harris DR. and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. A multisite randomized trial of a motivational intervention targeting multiple risks in youth living with HIV: initial effects on motivation, self-efficacy, and depression. J Adolesc Health, 2010 May; 46(5):422-8. (ATN 004) PMID 20413077 PMCID 2859210
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859210/

5 U01 HD 40533 and 5 U01 HD 40474
Cunningham CK, Rudy BJ, Xu J, Bethel J, Kapogiannis BG, Ahmad S, Wilson CM, Flynn P, and the Adolescent Trials Network for HIV/AIDS Interventions. Randomized Trial to Determine Safety and Immunogenicity of Two Strategies for Hepatitis B Vaccination in Healthy Urban Adolescents in the United States.  Pediatr Infect Dis J, 2010 Jun;29(6):530-4. (ATN 025) PMID 20173677 PMCID 3274492
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274492/

5 U01 HD 40533 and 5 U01 HD 40474
MacDonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW ATN 004 Protocol Team, Adolescent Trials Network for HIV/AIDS Interventions. Predictors of Medication Adherence in High Risk Youth of Color Living with HIV. J Pediatr Psychol, 2010 Jul; 35(6):593-601. (ATN 004) PMID 19755495 PMCID 2889251
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889251/

5 U01 HD 40533 and 5 U01 HD 40474
Wilson EC, Garofalo R, Harris DR, Herrick A, Martinez J, Martinez M, Belzer, M., the TAC, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Sexual risk taking among transgender male-to-female youths with different partner types. Am J of Public Health 2010 Aug; 100(8):1500-5. (ATN 039) PMID 20622176 PMCID 2901273
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901273/

5 U01 HD 40533 and 5 U01 HD 40474
Nugent NR, Brown LK, Belzer M, Harper GW, Nachman S, Naar-King S, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Youth living with HIV and problem substance use: elevated distress is associated with nonadherence and sexual risk. J Int Assoc Physicians AIDS Care, 2010 Mar-Apr;9(2):113-5.  (ATN 004) PMID 20133498 PMCID 3052784

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052784/

 

2009

5 U01 HD 40533 and 5 U01 HD 40474
Chutuape KS, Ziff M, Auerswald C, Castillo M, McFadden A, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. Examining Differences in Types and Location of Recruitment Venues for Young Males and Females from Urban Neighborhoods: Findings from a multi-site HIV prevention study. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 2009; 86 (1):31-41.  (ATN 016b) PMID 18972210 PMCID 2629524
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629524/

5 U01 HD 40533 and 5 U01 HD 40474
Wilson EC, Garofalo R, Harris DR, Herrick A, Martinez J, Martinez M, Belzer, M. and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Transgender female youth and sex work: HIV risk and a comparison of life factors related to engagement in sex work. AIDS Behav, 2009 Oct;13(5):902-13.  (ATN 039) PMID 19199022 PMCID 2756328
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756328/

5 U01 HD 40533 and 5 U01 HD 40474
Rudy BJ, Murphy DA, Harris R, Muenz L, Ellen J. Patient-Related Risks for Non-Adherence to Antiretroviral Therapy among HIV-Infected Youth in the United States: A Study of Prevalence and Interactions. AIDS Patient Care STDs, March 2009, 23(3):185-194.  (ATN 023b) PMID 19866536  PMCID 2856493
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856493/

5 U01 HD 40533 and 5 U01 HD 40474
Jennings JM, Ellen JM, Griffin-Deeds B, Harris DR, Muenz LR, Barnes W, Lee S, Auerswald CL, and the Adolescent Trials Network for HIV/AIDS Interventions. Youth Living with HIV and Partner-specific Risk for the Secondary Transmission of HIV. Sex Transm Dis, July 2009, 36(7): 439-444.  (ATN 016b) PMID 19525889 PMCID 2725398
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725398/

5 U01 HD 40533 and 5 U01 HD 40474
Rudy B, Sleasman J, Kapogiannis B, Wilson C, Bethel J, Ahmad S, Cunningham CK and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Short-Cycle Therapy in Adolescents After Continuous Therapy with Established Viral Suppression: The Impact on Viral Load Suppression.  AIDS Res Hum Retroviruses, June 2009, 25(6): 555-561.  (ATN 015) PMID 19534628  PMCID 2853866
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853866/

5 U01 HD 40533 and 5 U01 HD 40474
Jamil OB, Harper GW, Fernandez MI and the Adolescent Trials Network for HIV/AIDS Interventions. Sexual and Ethnic Identity Development among Gay/Bisexual/Questioning (GBQ) Male Ethnic Minority Adolescents. Cultur Divers Ethnic Minor Psychol, 2009, 15(3): 203–214.  (ATN 020) PMID 19594249 PMCID 2846409
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846409/

5 U01 HD 40533 and 5 U01 HD 40474
Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM, Tang J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Clear and Independent Associations of Several HLA-DRB1 Alleles with Different Antibody Responses to Hepatitis B Vaccination in Youth. Hum Genet. July 2009, 126:685–696. (ATN 052) PMID 19597844 PMCID 2771141
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771141/

5 U01 HD 40533 and 5 U01 HD 40474
Naar-King S, Parsons JT, Murphy DA, Chen X, Harris DR, Belzer M and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Improving Health Outcomes for Youth Living with Human Immunodeficiency Virus: A Multisite Randomized Trial of a Motivational Intervention Targeting Multiple Risks. Arch Pediatr Adolesc Med. 2009;163(12):1092-1098. (ATN 004) PMID 19996045  PMCID 2843389

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843389/

5 U01 HD 40533 and 5 U01 HD 40474
Clum G, Andrinopoulos K, Muessig K, Ellen J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Child Abuse in Young HIV Positive Women: Linkages to Risk. Qual Health Res 2009;19:1755. (ATN 053) PMID 19949224  PMCID 2840638
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840638/

4 R01 DA 014706
Clum G, Chung S, Ellen J. Mediators of HIV-Related Stigma and Risk Behavior in HIV Infected Young Women. AIDS Care, 2009 Nov;21(11):1455-62. (ATN 009) PMID: 20024724 PMCID 2860279

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860279/

 

2008

5 U01 HD 40533 and 5 U01 HD 40474
Kiser JJ, Fletcher CV, Flynn PM, Cunningham CK, Wilson CM, Kapogiannis BG, Major-Wilson H, Viani RM, Liu NX, Muenz LR, Harris DR, Havens PL, and the Adolescent Trials Network for HIV/AIDS Interventions. Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir-Ritonavir in Adolescents and Young Adults with Human Immunodeficiency Virus Infection. Antimicrob Agents Chemother, 2008;52:631-637. (ATN 056) PMID 18025112 PMCID 2224775
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2224775/

4 R01 DA 014706
Leonard L, Ellen JM. “The Story of My Life”: AIDS and ‘Autobiographical Occasions’. Qual Sociol, 2008:31:37-56.  (ATN 009)  PMID 20216918  PMCID 2834208
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834208/

5 U01 HD 40584
Deeds BG, Straub DM, Willard N, Castor J, Ellen J, Peralta L and the Adolescent Trials Network for HIV/AIDS Interventions. The Role of a Community Resource Assessments in the Development of 15 Adolescent Health Community-Researcher Partnerships. Progress in Community Health Partnerships: Research, Education, and Action. 2008:2(1):31-39.  (ATN 016a)  PMID 20208189  PMCID 2917594

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917594/

5 U01 HD 40533 and 5 U01 HD 40474
Warren JC, Fernández MI, Harper G, Hidalgo M, Jamil O, Torres RS. Predictors of Unprotected Sex among Young Sexually Active African American, Hispanic, and White MSM: The Importance of Ethnicity and Culture. AIDS Behav, 2008; 12(3):459-468. (ATN 020) PMID 17721725 PMCID 2832790
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832790/

5 U01 HD 40533 and 5 U01 HD 40474
Deeds BG, Castillo M, Beason Z, Cunningham SD, Ellen J, Peralta L and the Adolescent Trials Network for HIV/AIDS Interventions. An HIV Prevention Protocol Reviewed at 15 National Sites: How do Ethics Committees Protect Communities? Journal of Empirical Research on Human Research Ethics, 2008;3(2):77-86.  (ATN 016b) http://caliber.ucpress.net/doi/pdf/10.1525/jer.2008.3.2.77 PMID 19385747

5 U01 HD 40533 and 5 U01 HD 40474 
Jaspan HB, Cunningham CK, Tucker TJP, Wright PF, Self SG, Sheets RL, Rogers AS, Bekker L-G, Wilson CM, Duerr A, Wasserheit J, and the HIV Vaccine Adolescent Trials Working Group. Inclusion of Adolescents in Preventive HIV Vaccine Trials: Public Health Policy and Research Design at a Crossroads. J Acquir Immune Defic Syndr, 2008; 47:86-92. PMID 17984759

5 U01 HD 40533 and 5 U01 HD 40474
Sánchez-Cesáreo M, Harper GW, Neubauer L, Cellar D, Doll M, Robles G, Johnson J, Bangi A, Ellen J. Building bridges between organization development and community psychology: An integrative model for multi-site community based research. Interamerican Journal of Psychology, 2008; 42 (2):1-10.  (ATN 016a)  No PMID available.  URL: http://find.galegroup.com/gtx/infomark.do?&contentSet=IAC-Documents&type=retrieve&tabID=T002&prodId=IFME&docId=A198171083&source=gale&srcprod=IFME&userGroupName=birm97026&version=1.0

5 U01 HD 40533 and 5 U01 HD 40474
Harper GW, Neubauer LC, Bangi AK, Francisco VT, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Transdisciplinary Research and Evaluation for Community Health Initiatives. Health Promot Pract, 2008; 9(4):328-337.  (ATN 016a)  PMID 18936267 PMCID 2836480
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836480/

5 U01 HD 40533 and 5 U01 HD 40474
Hosek SG, Harper GW, Lemos D, Martinez J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. An Ecological Model of Stressors Experienced by Youth Newly Diagnosed with HIV. Journal of HIV/AIDS Prevention in Children and Youth, 2008; 9(2):192-218. (ATN 055) PMID 20216916 PMCID 2834206
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834206/

 

2007

5 U01 HD 40533 and 5 U01 HD 40474
Murphy DA, Hoffman D, Seage GR, Belzer M, Xu J, Durako S, Geiger M, and the Adolescent Trials Network for HIV/AIDS Interventions. Improving comprehension for HIV vaccine trial information among adolescents at risk for HIV. AIDS Care, 2007; 19(1):42-51.  (ATN 006) PMID 17265577

5 U01 HD 40533 and 5 U01 HD 40474
Sill A, Kreisel K, Deeds BG, Wilson CM, Constantine NT, Peralta L, Adolescent Trials Network for HIV/AIDS Interventions. Calibration and validation of an oral fluid-based sensitive/less sensitive assay to distinguish recent from established HIV-1 infections. J Clin Lab Anal, 2007:21:40-45.  (ATN 022) PMID 17245763

5 U01 HD 40533 and 5 U01 HD 40474
Yu XG, Lichterfeld M, Chetty S, LaBute MX, Williams KL, Mui SK, Miura T. Frahm N, Feeney ME, Tang Y, Pereyra F, Pfafferott K, Leslie A, Crawford H, Allgaier R, Hildebrand W, Kaslow R, Brander C, Allen TM, Rosenberg ES, Altfeld M, Kiepiela P, Vajpayee M, Goepfert PA, Goulder PJR, Walker BD. Mutually exclusive T-cell receptor induction and differential susceptibility to Human Immunodeficiency Virus Type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J Virol , 2007: 81:1619-1631. (ATN 026)  PMID 17121793

5 U01 HD 40497
Straub DM, Deeds BG, Willard N, Castor J, Peralta L, Ellen J, and the Adolescent Trials Network for HIV/AIDS Interventions. Partnership Selection and Formation: A Case Study of Developing Adolescent Health Community-Researcher Partnerships in 15 U.S. Communities.
J Adolesc Health, 2007;40:489-498. (ATN 016a) PMID 17531754

5 U01 HD 40506
Geanuracos C, Cunningham SD, Weiss G, Forte D, Henry-Reid LM, Ellen JM and the Adolescent Trials Network for HIV/AIDS Interventions. Use of geographic information systems for planning HIV prevention intervention planning for high-risk youth. Am J Public Health, 2007; 97:1974-1981.  (ATN 016a) PMID 17901452

4 R01 DA 014706
Trent M, Chung S, Clum G, Ellen J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions.  New sexually transmitted infections among adolescent girls infected with HIV. Sex Transm Infect, 2007; 83:468-469 (ATN 009) PMID 17699560

5 U01 HD 40533 and 5 U01 HD 40474
Bansal A, Yue L, Conway J, Yusim K, Tang J, Kappes J, Kaslow RA, Wilson CM, Goepfert PA. Immunological control of chronic HIV-1 Infection: HLA-mediated immune function and viral evolution in adolescents. AIDS, 2007;21(18):2387-2397. (ATN 026) PMID 18025875

5 U01 HD 40533 and 5 U01 HD 40474
Harper GW, Jamil OB, Wilson BDM. Collaborative community-based research as activism: giving voice and hope to lesbian, gay, and bisexual youth. Journal of Gay and Lesbian Psychotherapy, 2007;11(3):99-119. (ATN 020) DOI: 10.1300/J236v11n03_06

 

2006

5 U01 HD 40533 and 5 U01 HD 40474
Bansal A, Gough E, Ritter GD, Wilson CM, Mulenga J, Allen SA, Goepfert PA. Group M-based HIV-1 Gag peptides are frequently targeted by T-cells in chronically infected US and Zambian patients. AIDS, 2006;20(3):353-360.  (ATN 026) PMID: 16439868

5 U01 HD 40533 and 5 U01 HD 40474
Stephensen CB, Marquis GS, Kruzich LA, Douglas SD, Wilson CM. Vitamin D Status in Adolescents and Young Adults with HIV Infection. Am J Clin Nutr, 2006;83:1135-41.  (ATN 049) PMID 16685057

5 U01 HD 40533 and 5 U01 HD 40474
Ziff MA, Harper GW, Chutuape KS, Deeds BG, Futterman D, Francisco VT, Ellen JM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Laying the foundation for Connect to Protect®: A multi-site community mobilization intervention to reduce HIV/AIDS incidence and prevalence among urban youth. J Urban Health, 2006;83(3):506-522.  (ATN 016a) PMID 16739051  PMCID 2527202

5 U01 HD 40533 and 5 U01 HD 40474
Turnbull EL, Lopes AR. Jones NA, Cornforth D, Aldam D, Newton P, Pellegrino P, Williams I, Flower DR, Goepfert PA, Maini MK, Borrow P. HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. J Immunol, 2006; 176: 6130–6146.  (ATN 026) PMID: 16670322

5 U01 HD 40533 and 5 U01 HD 40474
Viani RM, Peralta L, Aldrovandi G, Kapogiannis BG, Mitchell R, Spector SA, Lie YS, Weidler JM, Bates MP, Liu N, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Prevalence of primary HIV-1 drug resistance among recently infected adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study. J Infect Dis, 2006;194:1505-1509. (ATN 029) PMID 17083034

 

2005

5 U01 HD40474
Mitchell R, Shah M, Ahmad S, Rogers AS, Ellenberg JH. Adolescent Medicine Trials Network for HIV / AIDS Interventions, A unified web-based Query and Notification System (QNS) for subject management, adverse events, regulatory, and IRB components of clinical trials. Clinical Trials 2005;2:61-71(11).  PMID: 16279580

 

Accepted Scientific Papers

5 U01 HD 40533 and 5 U01 HD 40474
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Harris DR, Price G, Baker A, Meyer WA, Wilson CM, Hazra R, Kapogiannis BG, Mulligan K, and the Adolescent Medicine Trials Network. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial. Clin Infec Dis, in press. (ATN 109) PMID 29020329

5 U01 HD 40533 and 5 U01 HD 40474
Knopf A, Lewis-Gilbert A, Zimet GD, Kapogiannis BG, Hosek SG, Fortenberry JD, Ott M, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Moral conflict and competing duties in the initiation of a biomedical HIV prevention trial with minor adolescents. Am J Bioeth, in press. Accepted 08/02/16. (ATN 113) PMC Journal/Author – In Process

5 U01 HD 40533 and 5 U01 HD 40474
Boyer C, Greenberg L, Korelitz J, Harper G, Stewart-Campbell R, Straub D, Arrington-Sanders R, Henry-Reid L, Futterman D, Lee S , Ellen J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Sexual Partner Characteristics, Relationship Type, and HIV Risk Among A Community Venue-based Sample of Urban Adolescent and Young Adult Men Who Have Sex With Men. Youth Soc, in press. Accepted 08/19/16. (ATN 040b) NIHMS 853567

UM1CA121974, 5 U01 HD 40533 and 5 U01 HD 40474
Kahn JA, Lee J, Rudy B, Belzer M, Palefsky JM, the AIDS Malignancy Consortium, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. HIV-infected young men demonstrate appropriate risk perceptions and beliefs about safer sexual behaviors after human papillomavirus vaccination. AIDS Behav, in press. Accepted 01/31/17. (AMC 072) PMID 28220313 PMCID 5563486 [Available on 2018-08-20]

5 U01 HD 40533 and 5 U01 HD 40474
Knopf AS, Liu N, Kapogiannis B, Zimet Z, Fortenberry JD, Hosek S, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Minors’ and young adults’ experiences of the research consent process in a Phase II safety study of pre-exposure prophylaxis for HIV. J Adolesc Health, in press.  Accepted  06/20/17. (ATN 137)

5 U01 HD 40533 and 5 U01 HD 40474
Wilson P, Cherenack E, Jadwin-Cakmak L, Harper G, and the Adolescent Trials Network for HIV/AIDS Interventions. Selection and Evaluation of Media for Behavioral Interventions Employing Critical Media Analysis. Health Promot Pract, in press. (ATN 090-104) PMID 28627319

5 U01 HD 40533 and 5 U01 HD 40474
Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Saberi P, Wilson CM, Gandhi M, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Comparing measures of adherence to HIV pre-exposure prophylaxis (PrEP) among adolescent and young men who have sex with men in the United States: an observational cohort study. Clin Infec Dis, in press. Accepted 08/09/17. (ATN 110)

5 U01 HD 40533 and 5 U01 HD 40474
Sanders R, Fields E, Greenberg L, Henry-Reid L, Stines S, Korelitz J, Kapogiannis B, Ellen J, Boyer C, and the Adolescent Trials Network for HIV/AIDS Interventions.
Does Venue Type Matter for HIV-Related Risk Behavior in Urban Adolescent and Young Adult Men Who Have Sex With Men? Youth Soc, in press. Accepted 08/09/17. (ATN 040b)

5 U01 HD 40533 and 5 U01 HD 40474
Miller RL, Santiago-Rivera OJ, Chiaramonte D, Acevedo-Polakovich I, Boyer CB, Ellen J, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Youth health outcomes from the Connect-to-Protect Coalitions to prevent adolescent HIV infections. Vulnerable Child Youth Stud, in press. Accepted 08/22/17. (ATN 040)

5 U01 HD 40533 and 5 U01 HD 40474
Hosek SG, Landovitz RJ, Kapogiannis BG, Siberry GK, Rudy B, Rutledge B, Liu N, Harris R, Mulligan K, Zimet GD, Mayer K, Anderson P, Kiser JJ, Lally M, Brothers J, Bojan K, Rooney J, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States. JAMA Pediatr, in press. Accepted 09/06/17. (ATN 113) PMID 28873128

5 U01 HD 40533 and 5 U01 HD 40474
Kowalczyk Mullins TL, Zimet, G, Lally, M, Xu J, Thornton S, Kahn JA, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. HIV Care Providers’ Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis (PrEP) to At-Risk Adolescents and Adults. AIDS Patient Care STD, in press. Accepted 09/25/17. (ATN 111)

5 U01 HD 40533 and 5 U01 HD 40474
Lally MA, van den Berg JJ, Westfall AO, Rudy BJ, Hosek S, Fortenberry JD, Monte D, Tanney MR, McFarland EJ, Xu J, Kapogiannis BG, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. HIV Continuum of Care for Youth in the United States. J Acquir Immune Defic Syndr, in press. Accepted 09/13/17. (ATN 125)

5 U01 HD 40533 and 5 U01 HD 40474
van den Berg JJ, Javanbakht M, Gorbach PM, Rudy BJ, Westfall AO, Wilson CM, Lally MA, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Partner Notification for Youth Living with HIV in 14 Cities in the United States. J Acquir Immune Defic Syndr, in press. Accepted 09/20/17. (ATN 125)

5 U01 HD 40533 and 5 U01 HD 40474
Gamarel KE, Westfall AO, Lally MA, Hosek S, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Tobacco use and sustained viral suppression in youth living with HIV. AIDS Behav, in press. Accepted 09/18/17. (ATN 125)

5 U01 HD 40533 and 5 U01 HD 40474
Doll M, Fortenberry JD, Roseland D, McAuliff K, Wilson CM, Boyer CB, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Linking HIV Negative Youth to Prevention Services in 12 US Cities: Barriers and Facilitators to Implementing the HIV Prevention Continuum. J Adolesc Health, in press. Accepted 10/09/17. (C2TaP)

5 U01 HD 40533 and 5 U01 HD 40474
Williams JC, Zhang X, Karki M, Chi Y, Wallet SM, Rudy BJ, Nichols SL, Goodenow MM, Sleasman JW, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Biomarkers of lymphocyte and macrophage activation define the profile of HIV associated inflammation in Youth Living with HIV. J Leukocyte Biol, in press. Accepted 10/19/17. (ATN 101) PMC Journal – In Process

5 U01 HD 40533 and 5 U01 HD 40474
Baker ZG, Javanbakht M, Lally M, Zimet G, Mierzwa S, Savel C, Gorbach P, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Predictors of over-reporting HIV pre-exposure prophylaxis (PrEP) adherence among young men who have sex with men (YMSM) in self-reported vs. biomarker data. AIDS Behav, in press. Accepted 10/23/17.  (ATN 123)

5 U01 HD 40533 and 5 U01 HD 40474
Reisner SL, Jadwin-Cakmak L, White Hughto JM, Martinez M, Salomon L, Harper GW, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Characterizing the HIV Prevention and Care Continua among U.S. Transgender Youth. AIDS Behav, in press. Accepted 10/23/17.  (ATN 130) PMID 29138982

5 U01 HD 40533 and 5 U01 HD 40474
Gamarel KE, Nichols S, Westfall AO, Lally MA, Kahler CW, Wilson CM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Associations between substance use risk and sexually transmitted infections among youth living with HIV. Sex Transm Infec, in press. Accepted 11/04/17. (ATN 125)

5 U01 HD 40533 and 5 U01 HD 40474
Gamarel KE, Nelson KM, Stephenson R, Santiago-Rivera OJ, Chiaramonte D, Miller RL, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Anticipated HIV stigma and delays in regular HIV testing behaviors among sexually-active young gay, bisexual, and other men who have sex with men and transgender women. AIDS Behav, in press. Accepted 12/02/17.  (ATN 095/105)

5 U01 HD 40533 and 5 U01 HD 40474
Miller RL, Strzyzykowski T, Lee KS, Acevedo-Polakovich I, Chiaramonte D, Spring H, Santiago-Rivera OJ, Boyer CB, Ellen JM, and the Adolescent Medicine Trials Network for HIV/AIDS Interventions. Structural effects on HIV risk among youth: A multi-level analysis.
AIDS Behav, in press. Accepted 12/26/17. (ATN 095/105)

 

 

This page is no longer updated. Please visit https://sites.cscc.unc.edu/atn/view/biblio/year for the latest list of ATN publications.